[{"title": "Top 10 Health Care ETFs", "desc": null, "date": "27/10/2011", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL2V0ZnMvdG9wLTEwLWhlYWx0aC1jYXJlLWV0ZnMtMTEyOTEyMzDSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVhhalZtYjFCc1lYZDVaeTAzVFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex founder's brother to retire from chief counsel post - Boston Business Journal", "desc": null, "date": "30/08/2011", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9ib3N0b24vbmV3cy8yMDExLzA4LzMwL3ZlcnRleC1mb3VuZGVycy1icm90aGVyLXRvLXJldGlyZS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXRiRUk1TnpnM2J6bHBibVZtVFJEaEFSaVdBU2dCTWdZcE5KU05uUWs=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Review: Dell PowerEdge VRTX Is Fast And Versatile", "desc": null, "date": "18/11/2013", "link": "news.google.com/articles/CBMiZmh0dHBzOi8vd3d3LmNybi5jb20vc2xpZGUtc2hvd3MvZGF0YS1jZW50ZXIvMjQwMTY0MDE4L3Jldmlldy1kZWxsLXBvd2VyZWRnZS12cnR4LWlzLWZhc3QtYW5kLXZlcnNhdGlsZdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVBhVjlGZUVaMmMwaHVNalpsVFJEaEFSamhBU2dCTWdtSllaSm1xbWRMRFFJ=-w200-h112-p-df", "media": "CRN", "site": null, "reporter": "Edward J. Correia", "sentiment": "positive"}, {"title": "Why Dell May Have Hit Home Run With New VRTX Server", "desc": null, "date": "07/06/2013", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vd3d3LmV3ZWVrLmNvbS9pbm5vdmF0aW9uL3doeS1kZWxsLW1heS1oYXZlLWhpdC1ob21lLXJ1bi13aXRoLW5ldy12cnR4LXNlcnZlci_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUliVEF3Ym5SU1ExOXhiMEpIVFJDd0FSaWVBaWdCTWdZTkFZckptQVU=-w200-h112-p-df", "media": "eWeek", "site": null, "reporter": "Chris J. Preimesberger", "sentiment": "negative"}, {"title": "Dell crams baby small-biz data center into a tower chassis", "desc": null, "date": "04/06/2013", "link": "news.google.com/articles/CBMiRmh0dHBzOi8vd3d3LnRoZXJlZ2lzdGVyLmNvbS8yMDEzLzA2LzA0L2RlbGxfcG93ZXJlZGdlX3ZydHhfc21iX3N5c3RlbS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWlWVmRzZDJ0QllXUXlZaTB0VFJDM0FSaVVBaWdCTWdZWkFJaXNsUVU=-w200-h112-p-df", "media": "The Register", "site": null, "reporter": "Timothy Prickett Morgan", "sentiment": "negative"}, {"title": "FDA approves Novartis' inhaled powder drug for cystic fibrosis infection", "desc": null, "date": "26/03/2013", "link": "news.google.com/articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcmVndWxhdG9yeS9mZGEtYXBwcm92ZXMtbm92YXJ0aXMtaW5oYWxlZC1wb3dkZXItZHJ1Zy1mb3ItY3lzdGljLWZpYnJvc2lzLWluZmVjdGlvbtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNUJOM2RrVDNwM2VERmhZakpGVFJDdEFSaWtBaWdCTWdzQkVJNnJHT2NPYjFsdW9n=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Michael Gibney", "sentiment": "negative"}, {"title": "Dell PowerEdge VRTX review", "desc": null, "date": "13/09/2013", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vd3d3LmFscGhyLmNvbS9kZWxsL2RlbGwtcG93ZXJlZGdlLXZydHgvMzIzMzYvZGVsbC1wb3dlcmVkZ2UtdnJ0eC1yZXZpZXcv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURaRVZ2TWs5UFkxTnZkVXBJVFJEQ0FSaURBaWdCTWdZWkpJcnJuUWM=-w200-h112-p-df", "media": "Alphr", "site": null, "reporter": "Dave Mitchell", "sentiment": "positive"}, {"title": "Dell PowerEdge VRTX Refresh (13G)", "desc": null, "date": "05/11/2014", "link": "news.google.com/articles/CBMiRGh0dHBzOi8vd3d3LnN0b3JhZ2VyZXZpZXcuY29tL3Jldmlldy9kZWxsLXBvd2VyZWRnZS12cnR4LXJlZnJlc2gtMTNn0gFIaHR0cHM6Ly93d3cuc3RvcmFnZXJldmlldy5jb20vcmV2aWV3L2RlbGwtcG93ZXJlZGdlLXZydHgtcmVmcmVzaC0xM2c_YW1w?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWlObUZmU1RaRWRuRmhYMWw0VFJDb0FSaXNBaWdCTWdZZE1JcHFxQVU=-w200-h112-p-df", "media": "StorageReview.com", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Behind the Scenes at Mississippi Studios with Sallie Ford, Tope, Zia McCabe of The Dandy Warhols, Natasha Kmeto ...", "desc": null, "date": "07/04/2014", "link": "news.google.com/articles/CBMinwFodHRwczovL3d3dy52cnR4bWFnLmNvbS9tZWRpYS9waG90by9iZWhpbmQtdGhlLXNjZW5lcy1hdC1taXNzaXNzaXBwaS1zdHVkaW9zLXdpdGgtc2FsbGllLWZvcmQtdG9wZS16aWEtbWNjYWJlLW9mLXRoZS1kYW5keS13YXJob2xzLW5hdGFzaGEta21ldG8tbGV3aS1sb25nbWlyZS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNXdSV2R0UjFoVGRsbzVTMUZNVFJDMEFSaVlBaWdCTWdzQk1vem9HS21nYmlud2tn=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Combo-Drug Trial For Cystic Fibrosis Scores", "desc": null, "date": "24/06/2014", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvbmV3cy92ZXJ0ZXgtY29tYm8tZHJ1Zy10cmlhbC1jeXN0aWMtMjIyMjAwNDk4Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW5jMWN3VFZOS2JGVklXa1kxVFJEMEFSak9BU2dCTWdZQlVKU0dMQWc=-w200-h112-p-df", "media": "Yahoo Movies Canada", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Significance of Round Numbers", "desc": null, "date": "13/11/2014", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vd3d3LmludmVzdGluZy5jb20vYW5hbHlzaXMvdGhlLXNpZ25pZmljYW5jZS1vZi1yb3VuZC1udW1iZXJzLTIzMjI4M9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNW5OV3BIUmkxWFJXSkJZazVFVFJEREFSaUNBaWdCTWdtSklJenBuS2cxY0FF=-w200-h112-p-df", "media": "Investing.com", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "A Weekend on the Waterfront: Recapping MusicfestNW 2014", "desc": null, "date": "29/08/2014", "link": "news.google.com/articles/CBMiWGh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL2Etd2Vla2VuZC1vbi10aGUtd2F0ZXJmcm9udC1yZWNhcHBpbmctbXVzaWNmZXN0bnctMjAxNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlaWEI1VlZwSWFtOHpWV05NVFJDRkFSajhBaWdCTWdhQklZYW1rZ28=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Eric Skelton", "sentiment": "positive"}, {"title": "Is this the world's best value investor?", "desc": null, "date": "17/12/2014", "link": "news.google.com/articles/CBMiMmh0dHBzOi8vYml6bmFrZW55YS5jb20vd29ybGRzLWJlc3QtdmFsdWUtaW52ZXN0b3Iv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXNiaTAzUzJGb2VYaExhRUZxVFJDMEFSaVlBaWdCTWdraFVaQUxvdWcxcndF=-w200-h112-p-df", "media": "Bizna Kenya", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Bombay Bicycle Club and Liz Lawrence at the Wonder Ballroom on April 22, 2014", "desc": null, "date": "22/04/2014", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2JvbWJheS1iaWN5Y2xlLWNsdWItYW5kLWxpei1sYXdyZW5jZS1hdC10aGUtd29uZGVyLWJhbGxyb29tLW9uLWFwcmlsLTIyLTIwMTQv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUJhek5EYkU1VlVGaGhUa3BrVFJDMUFSaVhBaWdCTWdZbFFvU050UVE=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Hippies and Ukuleles For The Win: An Evening with Amanda Palmer in Portland", "desc": null, "date": "27/11/2014", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL2hpcHBpZXMtYW5kLXVrdWxlbGVzLWZvci10aGUtd2luLWFuLWV2ZW5pbmctd2l0aC1hbWFuZGEtcGFsbWVyLWluLXBvcnRsYW5kL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW5TeTFvUWpGc1kzVkpla0psVFJDM0FSaVVBaWdCTWdhMWdvd1ROUVk=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Andrea Janda", "sentiment": "positive"}, {"title": "Vertex to Test New Cystic Fibrosis Drugs, Seeking Broader, More Effective Treatments", "desc": null, "date": "08/10/2015", "link": "news.google.com/articles/CBMihgFodHRwczovL3d3dy50aGVzdHJlZXQuY29tL2ludmVzdGluZy9zdG9ja3MvdmVydGV4LXRvLXRlc3QtbmV3LWN5c3RpYy1maWJyb3Npcy1kcnVncy1zZWVraW5nLWJyb2FkZXItbW9yZS1lZmZlY3RpdmUtdHJlYXRtZW50cy0xMzMxNzU5N9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNSVkpuVGxnNE5tSnFhV05qVFJDb0FSaXNBaWdCTWdhUmtaVG9PQWM=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Adam Feuerstein", "sentiment": "negative"}, {"title": "The Captain's Return: Day 2 of Project Pabst", "desc": null, "date": "21/07/2015", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1jYXB0YWlucy1yZXR1cm4tZGF5LTItb2YtcHJvamVjdC1wYWJzdC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXJUM1YyYTNsNWFqQmpja1JGVFJDRkFSajhBaWdCTWdZdEZZRFBsUWs=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Ollie Collins", "sentiment": "positive"}, {"title": "Morgan Stanley On Big Biotech: Upgrades, Pfizer, Vertex, Alexion, Cuts Gilead, Valeant - Gilead Sciences", "desc": null, "date": "02/10/2015", "link": "news.google.com/articles/CBMiKGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzU4ODM1MTnSASxodHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvNTg4MzUxOQ?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Dell PowerEdge FX2 review", "desc": null, "date": "19/01/2015", "link": "news.google.com/articles/CBMiPGh0dHBzOi8vd3d3Lml0cHJvLmNvbS9zZXJ2ZXIvMjM3MTYvZGVsbC1wb3dlcmVkZ2UtZngyLXJldmlld9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHpPRU14ZFZKVE5tNUdjbXB0VFJDM0FSaVRBaWdCTWdhSmdaUUdzUWM=-w200-h112-p-df", "media": "ITPro", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "The Gritty Birds Podcast: Ingrid Renan", "desc": null, "date": "16/06/2015", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1ncml0dHktYmlyZHMtcG9kY2FzdC1pbmdyaWQtcmVuYW4v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVRNVVV3VW5kSVkwcFFUbUpQVFJEZkFSamlBU2dCTWdZSllJaU1PUVU=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Jeni Wren Stottrup", "sentiment": "positive"}, {"title": "The Gritty Birds Podcast: Brandon Nikola of Habesha Lounge", "desc": null, "date": "07/07/2015", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1ncml0dHktYmlyZHMtcG9kY2FzdC1icmFuZG9uLW5pa29sYS1vZi1oYWJlc2hhLWxvdW5nZS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWhhbDlaYWtkU01qRlVNRU10VFJEREFSaURBaWdCTWdhdFZKU1BKUWc=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Jeni Wren Stottrup", "sentiment": "positive"}, {"title": "The Gritty Birds Podcast: Peter Vaughan Shaver of Sound Advice", "desc": null, "date": "23/06/2015", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1ncml0dHktYmlyZHMtcG9kY2FzdC1wZXRlci12YXVnaGFuLXNoYXZlci1vZi1zb3VuZC1hZHZpY2Uv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpWMTlsY21OaExWbG1TVXBxVFJEM0FSak1BU2dCTWdZcE5aNnVIUW8=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Jeni Wren Stottrup", "sentiment": "positive"}, {"title": "Memories, Music and the Remarkable Staying Power of Blonde Redhead", "desc": null, "date": "21/09/2015", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL21lbW9yaWVzLW11c2ljLWFuZC10aGUtcmVtYXJrYWJsZS1zdGF5aW5nLXBvd2VyLW9mLWJsb25kZS1yZWRoZWFkL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHdiRFpOU1RsMFNHNDNSV0pwVFJDRkFSajhBaWdCTWdhTk1vb29uZ1k=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Sam Gehrke", "sentiment": "positive"}, {"title": "Chris Stapleton at the Wonder Ballroom on Nov. 12, 2015", "desc": null, "date": "12/11/2015", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2NocmlzLXN0YXBsZXRvbi1hdC10aGUtd29uZGVyLWJhbGxyb29tLW9uLW5vdi0xMi0yMDE1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVZiR1JCUkRsSk9VRnpXRVJ2VFJDM0FSaVRBaWdCTWdZSm9vem51QVU=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Blonde Redhead at the Wonder Ballroom on Sept. 19, 2015", "desc": null, "date": "19/09/2015", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2Jsb25kZS1yZWRoZWFkLWF0LXRoZS13b25kZXItYmFsbHJvb20tb24tc2VwdC0xOS0yMDE1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNHRjbko2UW10TlNFbFVWbkZxVFJDM0FSaVRBaWdCTWdtQllvakF3aVE5WndJ=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Sam Gehrke", "sentiment": "positive"}, {"title": "Three Significant Biotech Stocks to Consider in March \u2013 Vertex Pharmaceuticals (NASDAQ:VRTX) in Focus", "desc": null, "date": "13/03/2015", "link": "news.google.com/articles/CBMigwFodHRwOi8vc3RvY2tzLm9yZy9iaW9waGFybWEvdGhyZWUtc2lnbmlmaWNhbnQtYmlvdGVjaC1zdG9ja3MtdG8tY29uc2lkZXItaW4tbWFyY2gtdmVydGV4LXBoYXJtYWNldXRpY2Fscy1uYXNkYXF2cnR4LWluLWZvY3VzLzI5MTI1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVJUa3M0TjE5U2RFNWpWVGhzVFJDakFSaTFBaWdCTWdPSk1RUQ=-w200-h112-p-df", "media": "Stocks.org", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Jamie xx at the Wonder Ballroom on July 25, 2015", "desc": null, "date": "25/07/2015", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2phbWllLXh4LWF0LXRoZS13b25kZXItYmFsbHJvb20tb24tanVseS0yNS0yMDE1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNDFUME42ZG1GSWQzWlJhRXR3VFJDM0FSaVRBaWdCTWdzUlFZam91Q1dhRlVrUGt3=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "J. Cole's 'Forest Hills Drive' Tour at the McDonald Theatre on March 2, 2015", "desc": null, "date": "02/03/2015", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2otY29sZXMtZm9yZXN0LWhpbGxzLWRyaXZlLXRvdXItYXQtdGhlLW1jZG9uYWxkLXRoZWF0cmUtb24tbWFyY2gtMi0yMDE1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXRVRmc1ZDFoSVZqRmxYMEZFVFJDM0FSaVRBaWdCTWdhcFJaYnRIUWs=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Pharma (VRTX) Moves Next-Generation Cystic Fibrosis Drugs Into New Clinical Trials", "desc": null, "date": "25/10/2016", "link": "news.google.com/articles/CBMihgFodHRwczovL3d3dy50aGVzdHJlZXQuY29tL2ludmVzdGluZy9zdG9ja3MvdmVydGV4LXBoYXJtYS1tb3Zlcy1uZXh0LWdlbmVyYXRpb24tY3lzdGljLWZpYnJvc2lzLWRydWdzLWludG8tbmV3LWNsaW5pY2FsLXRyaWFscy0xMzg2Njc4OdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXlWR1pIVW5JME9UUmhkekUwVFJDb0FSaXNBaWdCTWdhWm80eHFQUVU=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Adam Feuerstein", "sentiment": "negative"}, {"title": "UPDATED: Vertex, Moderna pair to create mRNA cystic fibrosis treatment", "desc": null, "date": "06/07/2016", "link": "news.google.com/articles/CBMiYmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvdmVydGV4LW1vZGVybmEtcGFpci10by1jcmVhdGUtbXJuYS1jeXN0aWMtZmlicm9zaXMtdHJlYXRtZW500gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURWMmhtTnpKRVNFMHlZMFZLVFJDb0FSaXNBaWdCTWdZdFpZaXZxUVk=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Gritty Birds Podcast: Sarah Bethe Nelson", "desc": null, "date": "09/06/2016", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1ncml0dHktYmlyZHMtcG9kY2FzdC1zYXJhaC1iZXRoZS1uZWxzb24v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVVVSFZNVlRkaVNqVmpMVlp5VFJEaEFSamhBU2dCTWdhdE5aVE9IUWs=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Jeni Wren Stottrup", "sentiment": "positive"}, {"title": "When Does Vertex Pharmaceuticals (VRTX) Become a Buy?", "desc": null, "date": "05/10/2016", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL3N0b2Nrcy93aGVuLWRvZXMtdmVydGV4LXBoYXJtYWNldXRpY2Fscy1iZWNvbWUtYS1idXktMTM4NDE2NTTSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXlWR1pIVW5JME9UUmhkekUwVFJDb0FSaXNBaWdCTWdhWm80eHFQUVU=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Chris Laudani", "sentiment": "negative"}, {"title": "The Secret to Vertex Pharmaceuticals' Success", "desc": null, "date": "06/01/2016", "link": "news.google.com/articles/CBMiUGh0dHBzOi8vd3d3LmZveGJ1c2luZXNzLmNvbS9tYXJrZXRzL3RoZS1zZWNyZXQtdG8tdmVydGV4LXBoYXJtYWNldXRpY2Fscy1zdWNjZXNz0gFUaHR0cHM6Ly93d3cuZm94YnVzaW5lc3MuY29tL21hcmtldHMvdGhlLXNlY3JldC10by12ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXN1Y2Nlc3MuYW1w?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJENnNUJWbTFJV21ZeFEyVXliMEpHVFJBOEdIZ29BVElEbFRJQw=-w200-h112-p-df", "media": "Fox Business", "site": null, "reporter": "Brian Feroldi", "sentiment": "positive"}, {"title": "What is Abbott's Revenue And Gross Profit Breakdown?", "desc": null, "date": "03/05/2016", "link": "news.google.com/articles/CBMic2h0dHBzOi8vd3d3LnRyZWZpcy5jb20vc3RvY2svYWJ0L2FydGljbGVzLzM0Nzk2OS9waWVycndoYXQtaXMtYWJib3R0cy1yZXZlbnVlLWFuZC1ncm9zcy1wcm9maXQtYnJlYWtkb3duLzIwMTYtMDUtMDPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNHRZakZwVUU1dWVXNUZkbVpQVFJDMUFSaVdBaWdCTWdNQlFBdw=-w200-h112-p-df", "media": "Trefis", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "CRISPR Therapeutics raises a $56M IPO, but patent battles, potential stock drops loom", "desc": null, "date": "19/10/2016", "link": "news.google.com/articles/CBMieGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvY3Jpc3ByLXRoZXJhcGV1dGljcy1yYWlzZXMtYS01Nm0taXBvLWJ1dC1wYXRlbnQtYmF0dGxlcy1wb3RlbnRpYWwtc3RvY2stZHJvcHMtbG9vbdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU1lbU5FUWpkMFgzQk9ZM2x0VFJDb0FSaXNBaWdCTWdhVkFvZ0lwZ1E=-w200-h112-p-df", "media": "Fierce Biotech", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Gritty Birds Podcast: Ken Stringfellow of The Posies", "desc": null, "date": "28/06/2016", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1ncml0dHktYmlyZHMtcG9kY2FzdC1rZW4tc3RyaW5nZmVsbG93LW9mLXRoZS1wb3NpZXMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHRXa050WjNCblkxVlVhVmhPVFJEaEFSamhBU2dCTWdhdFJKcVBuUWc=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Jeni Wren Stottrup", "sentiment": "positive"}, {"title": "How Has Lululemon's Revenue And EBITDA Composition Changed In The Last 5 Years?", "desc": null, "date": "30/03/2016", "link": "news.google.com/articles/CBMiigFodHRwczovL3d3dy50cmVmaXMuY29tL3N0b2NrL2x1bHUvYXJ0aWNsZXMvMzQ2OTI2L2hvdy1oYXMtbHVsdWxlbW9ucy1yZXZlbnVlLWFuZC1lYml0ZGEtY29tcG9zaXRpb24tY2hhbmdlZC1pbi10aGUtbGFzdC01LXllYXJzLzIwMTYtMDMtMzDSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtWVlkzTkZSRk1VNVpjR0pIVFJDcEFSaXJBaWdCTWdZQkVaSkJGd3c=-w200-h112-p-df", "media": "Trefis", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Gritty Birds Podcast: Deep Sea Diver", "desc": null, "date": "17/06/2016", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1ncml0dHktYmlyZHMtcG9kY2FzdC1kZWVwLXNlYS1kaXZlci_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTBNMFpJVmxsQ2VHSjNZMlZWVFJES0FSajVBU2dCTWdrZE5KSXBtdWxqckFF=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Jeni Wren Stottrup", "sentiment": "negative"}, {"title": "Mr. Bones: 'I Adore You' [Video Premiere]", "desc": null, "date": "08/03/2016", "link": "news.google.com/articles/CBMiRWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL21yLWJvbmVzLWktYWRvcmUteW91LXZpZGVvLXByZW1pZXJlL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTNOa1l6UTFweU1UbElabUpMVFJDNkFSaVBBaWdCTWdrTk1ZWnB6U01tcFFJ=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Chris Young", "sentiment": "positive"}, {"title": "The Gritty Birds Podcast: Tamar Aphek", "desc": null, "date": "20/05/2016", "link": "news.google.com/articles/CBMiRmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1ncml0dHktYmlyZHMtcG9kY2FzdC10YW1hci1hcGhlay_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5Oamt3U1VnMk0wbG1ORnA0VFJDM0FSaVVBaWdCTWdhSk1aN3ZIQW8=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Jeni Wren Stottrup", "sentiment": "positive"}, {"title": "The Bigger, the Better: Nothing But Thieves at the Wonder Ballroom", "desc": null, "date": "27/09/2016", "link": "news.google.com/articles/CBMiYmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1iaWdnZXItdGhlLWJldHRlci1ub3RoaW5nLWJ1dC10aGlldmVzLWF0LXRoZS13b25kZXItYmFsbHJvb20v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXBjRTV2WDNWRWRUaE9lbnBZVFJDRkFSajhBaWdCTWdhTlFaclZvQWc=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Bren Swogger", "sentiment": "positive"}, {"title": "The Enduring Weirdness of Aesop Rock", "desc": null, "date": "29/04/2016", "link": "news.google.com/articles/CBMiRmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1lbmR1cmluZy13ZWlyZG5lc3Mtb2YtYWVzb3Atcm9jay_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU9UR296YWtaclZrUlJlVmRNVFJDM0FSaVRBaWdCTWdhMUJJcHdrUW8=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Sam Gehrke", "sentiment": "positive"}, {"title": "Bands: Don't Go Dark on Social Media Between Shows", "desc": null, "date": "07/03/2016", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL2JhbmRzLWRvbnQtZ28tZGFyay1vbi1zb2NpYWwtbWVkaWEtYmV0d2Vlbi1zaG93cy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU1TbGRKVEdZelIzRktkbmMxVFJDM0FSaVRBaWdCTWdhNUFZclZzQVU=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Gritty Birds Podcast: Christopher Willits", "desc": null, "date": "27/05/2016", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1ncml0dHktYmlyZHMtcG9kY2FzdC1jaHJpc3RvcGhlci13aWxsaXRzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXVVazlRTUVkMVZuTlZSRXBHVFJDM0FSaVRBaWdCTWdZaHBJcU51UVU=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Jeni Wren Stottrup", "sentiment": "positive"}, {"title": "How to Get Press", "desc": null, "date": "21/10/2016", "link": "news.google.com/articles/CBMiMmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL2hvdy10by1nZXQtcHJlc3Mv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVhTVzlyT1dSME1UbEJkRk5CVFJDekFSaVpBaWdCTWdhVk1vcUpuZ2c=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Chris Young", "sentiment": "negative"}, {"title": "Five Portland Artists to Watch", "desc": null, "date": "21/07/2016", "link": "news.google.com/articles/CBMiQGh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL2ZpdmUtcG9ydGxhbmQtYXJ0aXN0cy10by13YXRjaC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVpXbk14YjBjMk1VRlVXVFoxVFJDRkFSajhBaWdCTWdZSllZeTBxQWc=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Ryan J. Prado, Eric Skelton & Jeni Wren Stottrup", "sentiment": "positive"}, {"title": "The Gritty Birds Podcast: Radiation City", "desc": null, "date": "03/05/2016", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1ncml0dHktYmlyZHMtcG9kY2FzdC1yYWRpYXRpb24tY2l0eS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVaM05aZGxWa2RrZERlVTA1VFJDeEFSaWNBaWdCTWdhRkVKcXdFQXM=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Jeni Wren Stottrup", "sentiment": "positive"}, {"title": "Aesop Rock, Rob Sonic and Homeboy Sandman at the Wonder Ballroom on May 7, 2016", "desc": null, "date": "07/05/2016", "link": "news.google.com/articles/CBMicmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2Flc29wLXJvY2stcm9iLXNvbmljLWFuZC1ob21lYm95LXNhbmRtYW4tYXQtdGhlLXdvbmRlci1iYWxscm9vbS1vbi1tYXktNy0yMDE2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlPSEJaUnpoeFpFTk9VMFZ0VFJDM0FSaVRBaWdCTWdZdGtvaHV1UVU=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Sam Gehrke", "sentiment": "positive"}, {"title": "Get the Gig: 14 Concert Booking Tips", "desc": null, "date": "19/04/2016", "link": "news.google.com/articles/CBMiRWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL2dldC10aGUtZ2lnLTE0LWNvbmNlcnQtYm9va2luZy10aXBzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUhUa2h0VFRGcFUwb3lVMEZHVFJDRkFSajhBaWdCTWdZSllvZ0dQUVE=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Chris Young", "sentiment": "positive"}, {"title": "Wolfmother and Deap Vally at the Wonder Ballroom on March 30, 2016", "desc": null, "date": "30/03/2016", "link": "news.google.com/articles/CBMiZmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL3dvbGZtb3RoZXItYW5kLWRlYXAtdmFsbHktYXQtdGhlLXdvbmRlci1iYWxscm9vbS1vbi1tYXJjaC0zMC0yMDE2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWhNVzVZVVdSdmFGUnNUWEJoVFJDM0FSaVRBaWdCTWdZQlFZN05vUWc=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Aesop Rock: A Bazooka Tooth Lives In The Rose City", "desc": null, "date": "17/08/2016", "link": "news.google.com/articles/CBMiSGh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL2EtYmF6b29rYS10b290aC1saXZlcy1pbi10aGUtcm9zZS1jaXR5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTJObXQ2T1ZGeU1FbzRkV2RaVFJDRkFSajhBaWdCTWdhdFJKRE5vUWc=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Sam Gehrke", "sentiment": "positive"}, {"title": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX): Get In While Markets Look The Other Way", "desc": null, "date": "29/09/2016", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vbWFya2V0ZXhjbHVzaXZlLmNvbS92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLWluY29ycG9yYXRlZC1uYXNkYXF2cnR4LWdldC1tYXJrZXRzLWxvb2std2F5LzIwMTYvMDkv0gFoaHR0cHM6Ly9tYXJrZXRleGNsdXNpdmUuY29tL3ZlcnRleC1waGFybWFjZXV0aWNhbHMtaW5jb3Jwb3JhdGVkLW5hc2RhcXZydHgtZ2V0LW1hcmtldHMtbG9vay13YXkvMjAxNi8wOS8?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVMV0V0YVRoalVVNHdaVVZQVFJDM0FSaVRBaWdCTWdZZHBaQ3JPUVk=-w200-h112-p-df", "media": "Market Exclusive", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Pharma (VRTX) Will Use Deals to Diversify Beyond Cystic Fibrosis", "desc": null, "date": "09/01/2017", "link": "news.google.com/articles/CBMidGh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL3N0b2Nrcy92ZXJ0ZXgtcGhhcm1hLXdpbGwtdXNlLWRlYWxzLXRvLWRpdmVyc2l0eS1iZXlvbmQtY3lzdGljLWZpYnJvc2lzLTEzOTQ3MTcz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVVhVFYwY1dwUE9WWXdiRWRqVFJDb0FSaXNBaWdCTWdhcFpZTE5xUVk=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Adam Feuerstein", "sentiment": "negative"}, {"title": "3 Stocks to Watch on Wednesday: Vertex Pharmaceuticals (VRTX), CSX (CSX) and International Business Machines ...", "desc": null, "date": "19/07/2017", "link": "news.google.com/articles/CBMipwFodHRwczovL2ludmVzdG9ycGxhY2UuY29tLzIwMTcvMDcvMy1zdG9ja3MtdG8td2F0Y2gtb24td2VkbmVzZGF5LXZlcnRleC1waGFybWFjZXV0aWNhbHMtaW5jb3Jwb3JhdGVkLXZydHgtY3N4LWNvcnBvcmF0aW9uLWNzeC1pbnRlcm5hdGlvbmFsLWJ1c2luZXNzLW1hY2hpbmVzLWNvcnAtaWJtL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFjbkZVUVZKNmIyeFFiamh4VFJDZkFSaS1BaWdCTWdhQnBJNUpRZ2M=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Karl Utermohlen", "sentiment": "positive"}, {"title": "More Than 30% Upside Seen For Vertex Stock On The Heels Of Phase 2 Data - Vertex Pharmaceuticals (NASDAQ:", "desc": null, "date": "19/07/2017", "link": "news.google.com/articles/CBMiKGh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hcnRpY2xlLzk3OTM3NTbSASxodHRwczovL3d3dy5iZW56aW5nYS5jb20vYW1wL2NvbnRlbnQvOTc5Mzc1Ng?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURURmRUVDJvdE5FOWFObVJ4VFJEaEFSamhBU2dCTWdZVms1THFPUWM=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Jayson Derrick", "sentiment": "negative"}, {"title": "Why Vertex Pharmaceuticals Stock Sank 42% in 2016", "desc": null, "date": "17/01/2017", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDE3LzAxLzE3L3doeS12ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXN0b2NrLXNhbmstNDItaW4tMjAxNi5hc3B40gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlTMmhqZGt4SVgxbHVSMU50VFJDekFSaVpBaWdCTWdZQms0NUd2UVU=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Cory Renauer", "sentiment": "negative"}, {"title": "Meet Hip-Hop's Freshest Collaborative Masterminds: Korgy & Bass [Song Premiere]", "desc": null, "date": "11/05/2017", "link": "news.google.com/articles/CBMia2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL21lZXQtaGlwLWhvcHMtZnJlc2hlc3QtY29sbGFib3JhdGl2ZS1tYXN0ZXJtaW5kcy1rb3JneS1iYXNzLXNvbmctcHJlbWllcmUv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNUlPVXR5V1ZScWFGUm1VRUZ2VFJDNkFSaVBBaWdCTWdzQmdJckFMdWNyVWFraWJB=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Chris Young", "sentiment": "positive"}, {"title": "Vertex and CRISPR Therapeutics to Co-Develop and Co-Commercialize CTX001 as CRISPR/Cas9 Gene Edited ...", "desc": null, "date": "12/12/2017", "link": "news.google.com/articles/CBMi1AFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE3MTIxMjAwNTE3MS9lbi9WZXJ0ZXgtYW5kLUNSSVNQUi1UaGVyYXBldXRpY3MtdG8tQ28tRGV2ZWxvcC1hbmQtQ28tQ29tbWVyY2lhbGl6ZS1DVFgwMDEtYXMtQ1JJU1BSQ2FzOS1HZW5lLUVkaXRlZC1UcmVhdG1lbnQtZm9yLVNpY2tsZS1DZWxsLURpc2Vhc2UtYW5kLSVDRSVCMi1UaGFsYXNzZW1pYdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNDNlbTVUVlZnM04wNXZlREJJVFJDM0FSaVRBaWdCTWdPWndnSQ=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Elephant Revival at the Wonder Ballroom on Feb. 11, 2017", "desc": null, "date": "11/02/2017", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2VsZXBoYW50LXJldml2YWwtYXQtdGhlLXdvbmRlci1iYWxscm9vbS1vbi1mZWItMTEtMjAxNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU1RVWQxVURVNGNYUm9aWEZCVFJEd0FSalNBU2dCTWdhbEpKRHNGUW8=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "A Q&A with V\u00c9RIT\u00c9", "desc": null, "date": "23/04/2017", "link": "news.google.com/articles/CBMiM2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL2EtcS1hLXdpdGgtdmVyaXRlL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTZjVWxmYTB3NFdGVlpZMlZ2VFJDUUFoaTVBU2dCTWdhdE5KeVBuUWs=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Bren Swogger", "sentiment": "positive"}, {"title": "A Sonic Catalogue of RAC", "desc": null, "date": "13/07/2017", "link": "news.google.com/articles/CBMiOmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL2Etc29uaWMtY2F0YWxvZ3VlLW9mLXJhYy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJkMW93UzJka2NVeHBlVE5oVFJDM0FSaVRBaWdCTWdhdFZKYXVwUWc=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Chris Young", "sentiment": "positive"}, {"title": "Three Portland Artists to Watch in 2017", "desc": null, "date": "01/02/2017", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RocmVlLXBvcnRsYW5kLWFydGlzdHMtdG8td2F0Y2gtaW4tMjAxNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNUZlVEZ4UlhGUWMxTTViVkZEVFJDRkFSajhBaWdCTWdPVk1SNA=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "The California Honeydrops at the Wonder Ballroom on Dec. 8, 2017", "desc": null, "date": "08/12/2017", "link": "news.google.com/articles/CBMiY2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL3RoZS1jYWxpZm9ybmlhLWhvbmV5ZHJvcHMtYXQtdGhlLXdvbmRlci1iYWxscm9vbS1vbi1kZWMtOC0yMDE3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUxaeTFrTkVkMU9IZEVOR1JpVFJDM0FSaVRBaWdCTWdZQk1Jb0xHZ2s=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Bebe Rexha, Spencer Ludwig and Daniel Skye at the Wonder Ballroom on March 13, 2017", "desc": null, "date": "13/03/2017", "link": "news.google.com/articles/CBMidmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2JlYmUtcmV4aGEtc3BlbmNlci1sdWR3aWctYW5kLWRhbmllbC1za3llLWF0LXRoZS13b25kZXItYmFsbHJvb20tb24tbWFyY2gtMTMtMjAxNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXBaalpLYTBwVFNFNW5MV28xVFJERkFSal9BU2dCTWdhcGRJeXRxUWM=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Bren Swogger", "sentiment": "positive"}, {"title": "The Domestics and Autonomics at the KINK Live Studio on Nov. 9, 2017", "desc": null, "date": "09/11/2017", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL3RoZS1kb21lc3RpY3MtYW5kLWF1dG9ub21pY3MtYXQtdGhlLWtpbmstbGl2ZS1zdHVkaW8tb24tbm92LTktMjAxNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpOVWhxVkhBd1dtVnlRakprVFJDOUFSaUxBaWdCTWdhRm9Jb0h3UVU=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Pharma Jumps 14% After Rival Releases Poor Cystic Fibrosis Drug Results", "desc": null, "date": "29/06/2018", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL3N0b2Nrcy92ZXJ0ZXgtcGhhcm1hLXNoYXJlcy1qdW1wLTE0NjM4NTk00gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNSVkpuVGxnNE5tSnFhV05qVFJDb0FSaXNBaWdCTWdhUmtaVG9PQWM=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Alexander Nicoll", "sentiment": "negative"}, {"title": "Vertex (VRTX) and Alexion (ALXN) Are Schooling Big Biotech", "desc": null, "date": "26/07/2018", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vb3Bpbmlvbi9hcnRpY2xlcy8yMDE4LTA3LTI2L3ZlcnRleC12cnR4LWFuZC1hbGV4aW9uLWFseG4tYXJlLXNjaG9vbGluZy1iaWctYmlvdGVjaNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVpkR2hPTW1OWFVIUklNV1k0VFJDM0FSaVRBaWdCTWdZQlFJS09TQU0=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Max Nisen", "sentiment": "positive"}, {"title": "CRISPR Therapeutics Set to Surge After FDA Lifts Hold on Human Trial", "desc": null, "date": "11/10/2018", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vbmV3cy9jcmlzcHItdGhlcmFwZXV0aWNzLXNldC1zdXJnZS1hZnRlci1mZGEtbGlmdHMtaG9sZC1odW1hbi10cmlhbC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTVPVEk1VTFSdGVIbzBWMEp2VFJDNEFSaVRBaWdCTWdrWkFwQ1F2V1U5Z0FN=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Daniel Liberto", "sentiment": "negative"}, {"title": "Vertex Announces Positive Phase 2 Data in Third Proof-of-Concept Study with the NaV1.8 Inhibitor VX-150", "desc": null, "date": "18/12/2018", "link": "news.google.com/articles/CBMioAFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE4MTIxODAwNTIyMy9lbi9WZXJ0ZXgtQW5ub3VuY2VzLVBvc2l0aXZlLVBoYXNlLTItRGF0YS1pbi1UaGlyZC1Qcm9vZi1vZi1Db25jZXB0LVN0dWR5LXdpdGgtdGhlLU5hVjEuOC1JbmhpYml0b3ItVlgtMTUw0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5XbTFMTW1GM09XTjZSbXhVVFJDaUFSaTNBaWdCTWdZWm80cEtRUVU=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Brave New World of Benson Amps", "desc": null, "date": "14/12/2018", "link": "news.google.com/articles/CBMiRGh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1icmF2ZS1uZXctd29ybGQtb2YtYmVuc29uLWFtcHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTFWVFZETW5OS2EySnVXbGRvVFJDM0FSaVRBaWdCTWdhZFU0NkxMUVk=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "3 Biotech Stocks With Rising Earnings Estimates Post Q4", "desc": null, "date": "13/03/2018", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzLzMtYmlvdGVjaC1zdG9ja3MtcmlzaW5nLWVhcm5pbmdzLTE1MDQwMzc1MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUliV3BJWVVoS2VuaGxSblpyVFJDeEFSaWNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Moderna (Nasdaq: MRNA) raises over $600-million through IPO", "desc": null, "date": "07/12/2018", "link": "news.google.com/articles/CBMibmh0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vbW9kZXJuYS1uYXNkYXEtbXJuYS1zdG9jay1yYWlzZXMtb3Zlci02MDAtbWlsbGlvbi10aHJvdWdoLWlwby10by1kZWJ1dC1vbi1mcmlkYXkv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iNkNnNUhjR2hMYjJveWJVTXlVbTR0VFJDbkFSaXRBaWdCTWc0QkFJcmtxS2Fod0pySlU4NHpGUQ=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Pregnant women's short-term use of paracetamol may protect the fetus - English articles", "desc": null, "date": "15/06/2018", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LnRpdGFuLnVpby5uby9lbmdsaXNoLzIwMTgvcHJlZ25hbnQtd29tZW5zLXNob3J0LXRlcm0tdXNlLXBhcmFjZXRhbW9sLW1heS1wcm90ZWN0LWZldHVzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVBSMjl6T0c1R2JHaGtTR2hNVFJDM0FSaVVBaWdCTWdZUmxaQklzZ1k=-w200-h112-p-df", "media": "Universitetet i Oslo", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Alphabet Median Pay Close To $200K", "desc": null, "date": "30/04/2018", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vbmV3cy9nb29nbGVzLWFscGhhYmV0LW1lZGlhbi1wYXktY2xvc2UtMjAway_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXpVSGR2VUUxSllVUnFWbFkzVFJDMEFSaVhBaWdCTWdZQklJeVFsQVU=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Donna Fuscaldo", "sentiment": "negative"}, {"title": "In Conversation with Roses & Revolutions", "desc": null, "date": "15/07/2018", "link": "news.google.com/articles/CBMiSGh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL2luLWNvbnZlcnNhdGlvbi13aXRoLXJvc2VzLXJldm9sdXRpb25zL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNWpVbWh5ZUZSRmVEbHJlbU52VFJDM0FSaVRBaWdCTWdtWlVwUVRwV2lhU1FJ=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Bren Swogger", "sentiment": "positive"}, {"title": "FDA Approves SYMDEKOTM (tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of Cystic Fibrosis in ...", "desc": null, "date": "12/02/2018", "link": "news.google.com/articles/CBMi5gFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE4MDIxMjAwNjMzNC9lbi9GREEtQXBwcm92ZXMtU1lNREVLT1RNLXRlemFjYWZ0b3JpdmFjYWZ0b3ItYW5kLWl2YWNhZnRvci10by1UcmVhdC10aGUtVW5kZXJseWluZy1DYXVzZS1vZi1DeXN0aWMtRmlicm9zaXMtaW4tUGVvcGxlLUFnZXMtMTItYW5kLU9sZGVyLXdpdGgtQ2VydGFpbi1NdXRhdGlvbnMtaW4tdGhlLUNGVFItR2VuZdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWZURTE2ZVZVelIwMXpMWGhqVFJESEFoaWFBU2dCTWdZQkU1QWxuZ2s=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Life as a Hologram: Superorganism Take Over the Wonder", "desc": null, "date": "07/09/2018", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL2xpZmUtYXMtYS1ob2xvZ3JhbS1zdXBlcm9yZ2FuaXNtLXRha2Utb3Zlci10aGUtd29uZGVyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUNhRVJEZEVkTWNtMVZheTFDVFJDM0FSaVRBaWdCTWdtRmNZcmtOR1pFVkFF=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Bren Swogger", "sentiment": "positive"}, {"title": "Where Folk Rock Meets Punk: Hop Along at the Wonder Ballroom", "desc": null, "date": "14/08/2018", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3doZXJlLWZvbGstcm9jay1tZWV0cy1wdW5rLWhvcC1hbG9uZy1hdC10aGUtd29uZGVyLWJhbGxyb29tL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXlkbFZKYlZONVNqWk1TbXBXVFJDMUFSaVhBaWdCTWdhaFJJaVBwUWM=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Bren Swogger", "sentiment": "positive"}, {"title": "Photos of Noah Cyrus at Wonder Ballroom on Oct. 24, 2018", "desc": null, "date": "24/10/2018", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL25vYWgtY3lydXMtYXQtd29uZGVyLWJhbGxyb29tLW9uLW9jdC0yNC0yMDE4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURaMmxwWlRsd1VFODJXa2x0VFJDM0FSaVRBaWdCTWdhQllvenRKUWc=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "ZZ Ward at the Wonder Ballroom on March 4, 2018", "desc": null, "date": "04/03/2018", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL3p6LXdhcmQtYXQtd29uZGVyLWJhbGxyb29tLW9uLW1hcmNoLTQtMjAxOC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUdXREV5TXpaYVVscDRVMm8xVFJDM0FSaVRBaWdCTWdhdE5KU3ZIUWs=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Gin Wigmore and Roses & Revolutions at the Wonder Ballroom on June 23, 2018", "desc": null, "date": "23/06/2018", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2dpbi13aWdtb3JlLWF0LXRoZS13b25kZXItYmFsbHJvb20tb24tanVuZS0yMy0yMDE4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDBVRWxxYlVOeVYwSXhablkyVFJDM0FSaVRBaWdCTWdhcElvUU1GZ28=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Bren Swogger", "sentiment": "positive"}, {"title": "Made In Portland", "desc": null, "date": "16/11/2018", "link": "news.google.com/articles/CBMiMmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL21hZGUtaW4tcG9ydGxhbmQv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUVlVWxxUTFOS2VqSmlkbGMwVFJDMUFSaVhBaWdCTWdrQm9KSnhPT2U0endF=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Chris Young", "sentiment": "positive"}, {"title": "Rainbow Kitten Surprise at the Wonder Ballroom on May 5, 2018", "desc": null, "date": "05/05/2018", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL3JhaW5ib3cta2l0dGVuLXN1cnByaXNlLWF0LXdvbmRlci1iYWxscm9vbS1vbi1tYXktNS0yMDE4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJVRXAyTTBrNU0zWnpNak5zVFJDMUFSaVhBaWdCTWdZbEpKVE5tUWs=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Jain and Drama Duo at Wonder Ballroom on Oct. 15, 2018", "desc": null, "date": "15/10/2018", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2phaW4tYW5kLWRyYW1hLWR1by1hdC13b25kZXItYmFsbHJvb20tb24tb2N0LTE1LTIwMTgv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW5URTlVWldkdlZYSXlhVE4wVFJDM0FSaVRBaWdCTWdZeFJacXZIUWs=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Tojo Andrianarivo", "sentiment": "positive"}, {"title": "Preparing spruce for climate changes - English articles", "desc": null, "date": "18/05/2018", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vd3d3LnRpdGFuLnVpby5uby9lbmdsaXNoLzIwMTgvcHJlcGFyaW5nLXNwcnVjZS1jbGltYXRlLWNoYW5nZXMuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVBORWgzVVc1YVN6VnJOV0Y0VFJDM0FSaVRBaWdCTWdrSmc1Q1ByV2U1YndF=-w200-h112-p-df", "media": "Universitetet i Oslo", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Has Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Got Enough Cash?", "desc": null, "date": "11/04/2019", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vbnoubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL3ZlcnRleC1waGFybWFjZXV0aWNhbHMtaW5jb3Jwb3JhdGVkLW5hc2RhcS12cnR4LTEyMjM0ODEwNi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTZSa3QzZFU5MVptaG9PRkZoVFJDSEFSajFBaWdCTWdhdE5JWndIUWs=-w200-h112-p-df", "media": "Yahoo New Zealand News", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Watermark holds Mark Makers Art Camp", "desc": null, "date": "29/09/2019", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vd3d3LmJlbWlkamlwaW9uZWVyLmNvbS9jb21tdW5pdHkvd2F0ZXJtYXJrLWhvbGRzLW1hcmstbWFrZXJzLWFydC1jYW1w0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTBlbVZGZERKb2EwSlhSbVpvVFJDM0FSaVRBaWdCTWdrTk1vb0luZWloVHdF=-w200-h112-p-df", "media": "Bemidji Pioneer", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration ...", "desc": null, "date": "06/06/2019", "link": "news.google.com/articles/CBMi5QFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE5MDYwNjAwNTg1My9lbi9WZXJ0ZXgtRXhwYW5kcy1pbnRvLU5ldy1EaXNlYXNlLUFyZWFzLWFuZC1FbmhhbmNlcy1HZW5lLUVkaXRpbmctQ2FwYWJpbGl0aWVzLVRocm91Z2gtRXhwYW5kZWQtQ29sbGFib3JhdGlvbi13aXRoLUNSSVNQUi1UaGVyYXBldXRpY3MtYW5kLUFjcXVpc2l0aW9uLW9mLUV4b25pY3MtVGhlcmFwZXV0aWNz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5XbTFMTW1GM09XTjZSbXhVVFJDaUFSaTNBaWdCTWdZWm80cEtRUVU=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Haley Johnsen and The Get Ahead at Bloodworks Live Studio on May 23, 2019", "desc": null, "date": "23/05/2019", "link": "news.google.com/articles/CBMibWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2hhbGV5LWpvaG5zZW4tYW5kLXRoZS1nZXQtYWhlYWQtYXQtYmxvb2R3b3Jrcy1saXZlLXN0dWRpby1vbi1tYXktMjMtMjAxOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWtXazAxZW1oVWJGcEVjemxuVFJDM0FSaVRBaWdCTWdZQlFaempJQW8=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "7 Underpriced Stocks With Biggest Upside as Market Stages 4Q Rally", "desc": null, "date": "08/10/2019", "link": "news.google.com/articles/CBMiZ2h0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vOS11bmRlcnByaWNlZC1zdG9ja3Mtd2l0aC1iaWdnZXN0LXVwc2lkZS1hcy1tYXJrZXQtc3RhZ2VzLTRxLXJhbGx5LTQ3NzI1MTPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDBSRm90YW5Bd09FRlhiMFEzVFJDOUFSaUxBaWdCTWdZWlk1QnJ1UVU=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Mark Kolakowski", "sentiment": "positive"}, {"title": "Vertex Pharmaceuticals fires executive for 'personal behavior' - Boston Business Journal", "desc": null, "date": "23/01/2019", "link": "news.google.com/articles/CBMiYmh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9ib3N0b24vbmV3cy8yMDE5LzAxLzIzL3ZlcnRleC1waGFybWFjZXV0aWNhbHMtZmlyZXMtZXhlY3V0aXZlLWZvci5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5RWFowUW1SUFFpMXZZakZEVFJDb0FSaXNBaWdCTWdhMVpJeVFyUVk=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Allison DeAngelis", "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals' $950 Million Bet on Curing Type 1 Diabetes Could Have an Astronomical Payoff", "desc": null, "date": "04/09/2019", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDE5LzA5LzA0L3ZlcnRleC1waGFybWFjZXV0aWNhbHMtOTUwLW1pbGxpb24tYmV0LW9uLWN1cmluZy10LmFzcHjSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWxiVU5oTW1SSmFEaHdka0pCVFJDeUFSaWJBaWdCTWdhbHBJaU1QUVE=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Keith Speights", "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals Posts Strong 3rd-Quarter Revenue Growth", "desc": null, "date": "31/10/2019", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXBvc3RzLXN0cm9uZy0zcmQtMTYwOTE2MjU1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlORUZFVm5wVGNrbE5Xa3AxVFJDckFSaW1BaWdCTWdhTkFxaEpqUXc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex and Arbor Biotechnologies Establish Collaboration to Discover Novel Proteins to Advance Discovery of Gene ...", "desc": null, "date": "03/01/2019", "link": "news.google.com/articles/CBMiuwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE5MDEwMzAwNTE5NC9lbi9WZXJ0ZXgtYW5kLUFyYm9yLUJpb3RlY2hub2xvZ2llcy1Fc3RhYmxpc2gtQ29sbGFib3JhdGlvbi10by1EaXNjb3Zlci1Ob3ZlbC1Qcm90ZWlucy10by1BZHZhbmNlLURpc2NvdmVyeS1vZi1HZW5lLUVkaXRpbmctVGhlcmFwaWVz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5XbTFMTW1GM09XTjZSbXhVVFJDaUFSaTNBaWdCTWdZWm80cEtRUVU=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Uncovering Songs and Stories with Sarah Clarke of Dirty Revival, Saeeda Wright and Moorea Masa", "desc": null, "date": "04/02/2019", "link": "news.google.com/articles/CBMiPmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3VuY292ZXJpbmctc29uZ3MtYW5kLXN0b3JpZXMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNVhNVnBVVEhadGRWcHBNbGN0VFJDRkFSajhBaWdCTWd1QlVJcU9MQ2ZCclBtYVZB=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Chris Young", "sentiment": "positive"}, {"title": "Could Vertex Pharmaceuticals Be a Millionaire-Maker Stock?", "desc": null, "date": "24/02/2019", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9jb3VsZC12ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLW1pbGxpb25haXJlLW1ha2VyLTE5MDAwMDA0MS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVhjbkJrT0hBMWFYSkNWVEJRVFJEQ0FSaURBaWdCTWdhQjRZYXV4UVE=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Keith Speights", "sentiment": "negative"}, {"title": "Vertex to Acquire Semma Therapeutics With a Goal of Developing Curative Cell-Based Treatments for Type 1 Diabetes", "desc": null, "date": "03/09/2019", "link": "news.google.com/articles/CBMiqgFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE5MDkwMzAwNTIyNy9lbi9WZXJ0ZXgtdG8tQWNxdWlyZS1TZW1tYS1UaGVyYXBldXRpY3MtV2l0aC1hLUdvYWwtb2YtRGV2ZWxvcGluZy1DdXJhdGl2ZS1DZWxsLUJhc2VkLVRyZWF0bWVudHMtZm9yLVR5cGUtMS1EaWFiZXRlc9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVpXVGhtUkdkWFYzRk5TRk14VFJDbEFSaXhBaWdCTWdNQlFBUQ=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Lennon Stella and Valley at Wonder Ballroom on April 7, 2019", "desc": null, "date": "07/04/2019", "link": "news.google.com/articles/CBMiYGh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2xlbm5vbi1zdGVsbGEtYW5kLXZhbGxleS1hdC13b25kZXItYmFsbHJvb20tb24tYXByaWwtNy0yMDE5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUNSaTB3T0ZWaFNHbzBkRFJ2VFJERkFSal9BU2dCTWdZcFpJU1BwUWM=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Expands Collaboration With CRISPR, Acquires Exonics", "desc": null, "date": "07/06/2019", "link": "news.google.com/articles/CBMiZGh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvdmVydGV4LWV4cGFuZHMtY29sbGFib3JhdGlvbi1jcmlzcHItYWNxdWlyZXMtMTMyNDAxODE1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNW5WeTFsVWkwelZWTmhSelpZVFJDeUFSaWJBaWdCTWdzSkVJcVVuR1VXSTB0eU5R=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Robert Henry Band: 'Give Me A Guitar' [Song Premiere]", "desc": null, "date": "30/05/2019", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3JvYmVydC1oZW5yeS1iYW5kLWdpdmUtbWUtYS1ndWl0YXItc29uZy1wcmVtaWVyZS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUxUVXhIYUVKM2RIZG1UWGx0VFJDM0FSaVRBaWdCTWdZQkZwYnJsUWs=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Chris Young", "sentiment": "positive"}, {"title": "Musician Loading Zones Launch In Portland", "desc": null, "date": "13/03/2019", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL211c2ljaWFuLWxvYWRpbmctem9uZXMtbGF1bmNoLWluLXBvcnRsYW5kL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU1WVWRTT0VadVdGQndibUZmVFJDRkFSajhBaWdCTWdZZFJJeUxIUVk=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Chris Young", "sentiment": "negative"}, {"title": "Opera: Stripped Down & Amplified featuring May Arden, Zia McCabe of The Dandy Warhols and Louise Woodward of ...", "desc": null, "date": "05/06/2019", "link": "news.google.com/articles/CBMifWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL29wZXJhLWZlYXQtbWF5LWFyZGVuLXppYS1tY2NhYmUtbG91aXNlLXdvb2R3YXJkLWF0LWJsb29kd29ya3MtbGl2ZS1zdHVkaW8tb24tanVuZS01LTIwMTkv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdOM2xOUW0wd1pUQlZOVzAyVFJDM0FSaVRBaWdCTWdZTk1wN21IQW8=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Better Buy: CRISPR Therapeutics vs. Vertex Pharmaceuticals", "desc": null, "date": "06/01/2019", "link": "news.google.com/articles/CBMiWWh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvYmV0dGVyLWJ1eS1jcmlzcHItdGhlcmFwZXV0aWNzLXZzLTE0MDkwMDgyMC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXdlVzVYV1dnNWFuaFVhWEZGVFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": "Cory Renauer", "sentiment": "negative"}, {"title": "Weight Watchers International (WW) Q2 2019 earnings report", "desc": null, "date": "06/08/2019", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vd2VpZ2h0LXdhdGNoZXJzLWludGVybmF0aW9uYWwtd3ctc3RvY2stcTItMjAxOS1lYXJuaW5ncy1yZXN1bHRzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWFVR3BwVlU1UVZXdFVWRVpUVFJDb0FSaXRBaWdCTWdZSkFvNUhBUTA=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex (VRTX) Drops 20% After Failed Drug Trial", "desc": null, "date": "16/10/2020", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vdmVydGV4LXZydHgtZHJvcHMtMjAtYWZ0ZXItZmFpbGVkLWRydWctdHJpYWwtNTA4MjYyN9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUZabG95VURkcWJrWTBTRXB5VFJDZUFSaV9BaWdCTWdZQmdJaVZwQWM=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Alan S. Farley", "sentiment": "negative"}, {"title": "VRTX Stock: A Model Of Relative Strength", "desc": null, "date": "09/04/2020", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vcmVzZWFyY2gvc3dpbmctdHJhZGluZy92cnR4LXN0b2NrLW1vZGVsLW9mLXJlbGF0aXZlLXN0cmVuZ3RoL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVhNM2xWWWtweGFVTndRbVZKVFJDcEFSaXJBaWdCTWdrRkFZYWxCU3BWaHdJ=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Justin Nielsen", "sentiment": "positive"}, {"title": "Vertex Pharmaceuticals (VRTX) Q1 2020 earnings preview", "desc": null, "date": "28/04/2020", "link": "news.google.com/articles/CBMiXmh0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vd2hhdC10by1leHBlY3QtZnJvbS12ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtcTEtMjAyMC1lYXJuaW5ncy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXdRamQwU0VWWmRUWTJVR3hxVFJDd0FSaWZBaWdCTWdrQkFZakNET2lSb0FN=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Local gym uses soft opening to give back to Missoula", "desc": null, "date": "01/12/2020", "link": "news.google.com/articles/CBMijwFodHRwczovL3d3dy5tb250YW5hcmlnaHRub3cuY29tL21pc3NvdWxhL2xvY2FsLWd5bS11c2VzLXNvZnQtb3BlbmluZy10by1naXZlLWJhY2stdG8tbWlzc291bGEvYXJ0aWNsZV9mODliZjY5Yy0zNDJhLTExZWItOGY4My0xNzgzMzM2NTczODcuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHlhWGx2VDNkNFkxQkpVa1I2VFJDb0FSaXNBaWdCTWdZQmtZTHN0UVk=-w200-h112-p-df", "media": "Montana Right Now", "site": null, "reporter": "Tessa Jeanette Nadeau", "sentiment": "positive"}, {"title": "Vertex Forward: Illustrating our scientific strategy | Vertex", "desc": null, "date": "14/09/2020", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vd3d3LnZydHguY29tL2VuLXVzL3N0b3JpZXMvdmVydGV4LWZvcndhcmQtaWxsdXN0cmF0aW5nLW91ci1zY2llbnRpZmljLXN0cmF0ZWd5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDJhVFZOUTJKc2RVOXJjMnRCVFJDU0FSalpBaWdCTWdaQkVJYlZwQWM=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Where Will Vertex Pharmaceuticals Be in 10 Years?", "desc": null, "date": "02/02/2020", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzAyLzAyL3doZXJlLXdpbGwtdmVydGV4LXBoYXJtYWNldXRpY2Fscy1iZS1pbi0xMC15ZWFycy5hc3B40gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXJhV2xQZWtjNE5ISXhkbVJvVFJDM0FSaVRBaWdCTWdtUkVvWVBsU3A2MVFB=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Keith Speights", "sentiment": "positive"}, {"title": "Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi-Year Collaboration to Discover and Develop Novel ...", "desc": null, "date": "27/04/2020", "link": "news.google.com/articles/CBMiywFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMDQyNzAwNTE1MS9lbi9WZXJ0ZXgtUGhhcm1hY2V1dGljYWxzLWFuZC1BZmZpbmlhLVRoZXJhcGV1dGljcy1Fc3RhYmxpc2gtTXVsdGktWWVhci1Db2xsYWJvcmF0aW9uLXRvLURpc2NvdmVyLWFuZC1EZXZlbG9wLU5vdmVsLUFBVi1DYXBzaWRzLWZvci1HZW5ldGljLVRoZXJhcGllc9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5XbTFMTW1GM09XTjZSbXhVVFJDaUFSaTNBaWdCTWdZWm80cEtRUVU=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals Selects TRIA to Design Laboratory and Office for New 268,000 SF VCGT Research Site", "desc": null, "date": "16/07/2020", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vd3d3LmNubi5jb20vYnVzaW5lc3MvbmV3c2ZlZWRzL3BybmV3c3dpcmUvMjAyMDA3MTYxMzQ3UFJfTkVXU19VU1BSX19fX19ORTY1ODM5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVZlVUpxYjFOd1NXUTJaSE5pVFJEQ0FSaUVBaWdCTWdZQklKQUlPUWM=-w200-h112-p-df", "media": "CNN", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Pharmaceuticals Selects TRIA to Design Laboratory and Office for New 268,000 SF VCGT Research Site", "desc": null, "date": "16/07/2020", "link": "news.google.com/articles/CBMilAFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9yZWxlYXNlcy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXNlbGVjdHMtdHJpYS10by1kZXNpZ24tbGFib3JhdG9yeS1hbmQtb2ZmaWNlLWZvci1uZXctMjY4LTAwMC1zZi12Y2d0LXJlc2VhcmNoLXNpdGUv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVZlVUpxYjFOd1NXUTJaSE5pVFJEQ0FSaUVBaWdCTWdZQklKQUlPUWM=-w200-h112-p-df", "media": "BioSpace", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Wipers: 'Is This Real?' Yes, This Was Real", "desc": null, "date": "19/08/2020", "link": "news.google.com/articles/CBMiR2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3dpcGVycy1pcy10aGlzLXJlYWwteWVzLXRoaXMtd2FzLXJlYWwv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDBSV1JOTFdGeE9XdFJjVmREVFJEQ0FSaUVBaWdCTWdZdFZJcVBKUWc=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Mark Lore", "sentiment": "positive"}, {"title": "Where Will Vertex Pharmaceuticals Be in 5 Years?", "desc": null, "date": "03/10/2020", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzEwLzAzL3doZXJlLXdpbGwtdmVydGV4LXBoYXJtYWNldXRpY2Fscy1iZS1pbi01LXllYXJzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXBZbWxHTTFaNmIycHpZbVpUVFJDM0FSaVRBaWdCTWdhTlk1Q0hOZ1k=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Jim Halley", "sentiment": "positive"}, {"title": "3 Blue-Chip Biotech Stocks Hitting New Highs", "desc": null, "date": "08/04/2020", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vMy1ibHVlLWNoaXAtYmlvdGVjaC1zdG9ja3MtaGl0dGluZy1uZXctaGlnaHMtNDgwMjIwMNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVBOakY1UWtRMlltTnZiMFYxVFJDZUFSaV9BaWdCTWdhQnNwQXdPUWM=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Alan S. Farley", "sentiment": "negative"}, {"title": "Skyhawk and Vertex Establish a Strategic Collaboration to Discover and Develop Novel Small Molecules that Modulate ...", "desc": null, "date": "22/12/2020", "link": "news.google.com/articles/CBMizQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMTIyMjAwNTAzMi9lbi9Ta3loYXdrLWFuZC1WZXJ0ZXgtRXN0YWJsaXNoLWEtU3RyYXRlZ2ljLUNvbGxhYm9yYXRpb24tdG8tRGlzY292ZXItYW5kLURldmVsb3AtTm92ZWwtU21hbGwtTW9sZWN1bGVzLXRoYXQtTW9kdWxhdGUtUk5BLVNwbGljaW5nLWZvci1TZXJpb3VzLURpc2Vhc2Vz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVpXVGhtUkdkWFYzRk5TRk14VFJDbEFSaXhBaWdCTWdNQlFBUQ=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex CEO: How Jeffrey Leiden Turned Brilliance Into Billions", "desc": null, "date": "16/07/2020", "link": "news.google.com/articles/CBMifGh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy9tYW5hZ2VtZW50L2xlYWRlcnMtYW5kLXN1Y2Nlc3MvdmVydGV4LWNlby1ob3ctamVmZnJleS1sZWlkZW4tdHVybmVkLWJyaWxsaWFuY2UtaW50by1iaWxsaW9ucy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdlWGRDYmxOaE5XcFBURGsyVFJDb0FSaXJBaWdCTWdZdE5aeXVtUWs=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Better Buy: Vertex Pharmaceuticals vs. Regeneron", "desc": null, "date": "17/07/2020", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzA3LzE3L2JldHRlci1idXktdmVydGV4LXBoYXJtYWNldXRpY2Fscy12cy1yZWdlbmVyb24uYXNweNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXlOMEpwY1U1UWVGcDJXalZJVFJDd0FSaWVBaWdCTWdhdFU0eVBLUVk=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Keith Speights", "sentiment": "negative"}, {"title": "Looking for a summer internship? Here's why Vertex is the best place to launch your career | Vertex", "desc": null, "date": "10/02/2020", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LnZydHguY29tL3ZlcnRleC1jdWx0dXJlL2xvb2tpbmctc3VtbWVyLWludGVybnNoaXAtaGVyZXMtd2h5LXZlcnRleC1iZXN0LXBsYWNlLWxhdW5jaC15b3VyLWNhcmVlctIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtibXhaU0ZkSWNWZFZjRWg0VFJDYUFSaklBaWdCTWdhQndvU2d6Z0k=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "3 Charts Suggest Traders Will Remain Bullish on Biotech", "desc": null, "date": "11/03/2020", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vMy1jaGFydHMtc3VnZ2VzdC10cmFkZXJzLXdpbGwtcmVtYWluLWJ1bGxpc2gtb24tYmlvdGVjaC00Nzk5MzE10gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUJUalpJTUV4RVowcHdaMUZrVFJDMEFSaVhBaWdCTWdZSkFvWktxUVk=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Casey Murphy", "sentiment": "negative"}, {"title": "Moderna and Vertex Establish New Collaboration to Treat Cystic Fibrosis Using Gene Editing", "desc": null, "date": "16/09/2020", "link": "news.google.com/articles/CBMikwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMDkxNjAwNTkxNS9lbi9Nb2Rlcm5hLWFuZC1WZXJ0ZXgtRXN0YWJsaXNoLU5ldy1Db2xsYWJvcmF0aW9uLXRvLVRyZWF0LUN5c3RpYy1GaWJyb3Npcy1Vc2luZy1HZW5lLUVkaXRpbmfSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDROM1l4ZGxCT05sbDVTMWhZVFJDaUFSaTNBaWdCTWdZQmtKTGxOQWM=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "CRISPR Therapeutics and Vertex Pharmaceuticals Announce FDA Regenerative Medicine Advanced Therapy (RMAT ...", "desc": null, "date": "11/05/2020", "link": "news.google.com/articles/CBMi_AFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMC8wNS8xMS8yMDMxMTQ1LzAvZW4vQ1JJU1BSLVRoZXJhcGV1dGljcy1hbmQtVmVydGV4LVBoYXJtYWNldXRpY2Fscy1Bbm5vdW5jZS1GREEtUmVnZW5lcmF0aXZlLU1lZGljaW5lLUFkdmFuY2VkLVRoZXJhcHktUk1BVC1EZXNpZ25hdGlvbi1HcmFudGVkLXRvLUNUWDAwMS1mb3ItdGhlLVRyZWF0bWVudC1vZi1TZXZlcmUtSGVtb2dsb2Jpbm9wYXRoaWVzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWtTazFtUzB4U1QzQjRPVFUyVFJEaEFSamhBU2dCTWdhTndJTHF4QUk=-w200-h112-p-df", "media": "GlobeNewswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "\u2013 Evolutionary flaws disprove the theory of intelligent design - English articles", "desc": null, "date": "11/03/2020", "link": "news.google.com/articles/CBMiYGh0dHBzOi8vd3d3LnRpdGFuLnVpby5uby9lbmdsaXNoLzIwMjAvZXZvbHV0aW9uYXJ5LWZsYXdzLWRpc3Byb3ZlLXRoZW9yeS1pbnRlbGxpZ2VudC1kZXNpZ24uaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVRiMUpMZW1saFVFdG9UVTR4VFJDM0FSaVRBaWdCTWdhRk1wWnNJUWc=-w200-h112-p-df", "media": "Universitetet i Oslo", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "CRISPR Therapeutics Gene Therapy CTX001 Gets PRIME Status", "desc": null, "date": "23/09/2020", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9jcmlzcHItdGhlcmFwZXV0aWNzLWdlbmUtdGhlcmFweS1jdHgwMDEtMTUwMzAzMjY2Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXBPRkZuUkZkNlYzZFlZMGhoVFJDeUFSaWJBaWdCTWdNTlVnWQ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Photos of Chastity Belt at Wonder Ballroom on Feb. 5, 2020", "desc": null, "date": "05/02/2020", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2NoYXN0aXR5LWJlbHQtYXQtd29uZGVyLWJhbGxyb29tLW9uLWZlYi01LTIwMjAv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWlkRUV6VW1KelRtUkRWMWgyVFJDMkFSaVVBaWdCTWdZTm9vd292UVU=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Ignacio Quintana", "sentiment": "positive"}, {"title": "The Sounds of The Rose City Revolution [Playlist]", "desc": null, "date": "10/06/2020", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL3RoZS1zb3VuZHMtb2YtdGhlLXJvc2UtY2l0eS1yZXZvbHV0aW9uLXBsYXlsaXN0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVBPVzR0VTBocGFHRkdjbFZoVFJEQ0FSaURBaWdCTWdZWkVJYXVsUVU=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Chris Young", "sentiment": "positive"}, {"title": "In Dark Times, I Sing of Trees", "desc": null, "date": "22/04/2020", "link": "news.google.com/articles/CBMiP2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL2FydGljbGVzL2luLWRhcmstdGltZXMtaS1zaW5nLW9mLXRyZWVzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVRZbTlpTkhGTU5tVkRRMHBuVFJDM0FSaVRBaWdCTWdZQndvUkdTZ00=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Reverend Horton Heat, Bloodshot Bill and The Buttertones at Wonder Ballroom on Jan. 31, 2020", "desc": null, "date": "31/01/2020", "link": "news.google.com/articles/CBMifmh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL3JldmVyZW5kLWhvcnRvbi1oZWF0LWJsb29kc2hvdC1iaWxsLWFuZC10aGUtYnV0dGVydG9uZXMtYXQtd29uZGVyLWJhbGxyb29tLW9uLWphbi0zMS0yMDIwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW5RazFwWVRNdE9HSlFaWGROVFJDM0FSaVRBaWdCTWdhZFpvb3JwZ1k=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Insider Trading Weekly \u2013 Selling Continues (including 4 insiders at PTON) with an Uptick in Buying: PTON, KHC, DIS ...", "desc": null, "date": "13/11/2020", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vYm9hcmRyb29tYWxwaGEvbmV3cy9pbnNpZGVyLXRyYWRpbmctd2Vla2x5LXVwZGF0ZS0xM9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU9kSFl6UTJ0MGVIcE5aRWhhVFJDbUFSaXdBaWdCTWdZQlFKUmdvd1k=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Lilly to Acquire Private Biotech for Boosting Pain Portfolio", "desc": null, "date": "16/10/2020", "link": "news.google.com/articles/CBMiWGh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9tb3ZpZXMvbGlsbHktYWNxdWlyZS1wcml2YXRlLWJpb3RlY2gtYm9vc3RpbmctMTcwNTA1MjY0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDVaMEpQVjIxTlptTm5WMjlSVFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Forward: Diving into type 1 diabetes | Vertex", "desc": null, "date": "02/11/2021", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vd3d3LnZydHguY29tL2VuLXVzL3N0b3JpZXMvdmVydGV4LWZvcndhcmQtZGl2aW5nLXR5cGUtMS1kaWFiZXRlcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXZjRkZDVG5KcVRXdHVjVWxHVFJDU0FSalpBaWdCTWdNQkFpdw=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "HMP Global Announces Rollout of VRTX, Elevating the Virtual Event Experience", "desc": null, "date": "25/01/2021", "link": "news.google.com/articles/CBMigwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2htcC1nbG9iYWwtYW5ub3VuY2VzLXJvbGxvdXQtb2YtdnJ0eC1lbGV2YXRpbmctdGhlLXZpcnR1YWwtZXZlbnQtZXhwZXJpZW5jZS0zMDEyMTQwOTEuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXdSbTl2YzBacWFuUXpXbWxtVFJDaUFSaTNBaWdCTWdZaFpaYk5MUWc=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals Stock Is Likely To Rebound From $180 Levels Currently", "desc": null, "date": "04/10/2021", "link": "news.google.com/articles/CBMihgFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dyZWF0c3BlY3VsYXRpb25zLzIwMjEvMTAvMDQvdmVydGV4LXBoYXJtYWNldXRpY2Fscy1zdG9jay1pcy1saWtlbHktdG8tcmVib3VuZC1mcm9tLTE4MC1sZXZlbHMtY3VycmVudGx5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVpjbEpQV2poUWRWZENOakpKVFJDM0FSaVRBaWdCTWdZWkZvSHFYUUU=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "3 Reasons It's Not Too Late to Buy Vertex Pharmaceuticals", "desc": null, "date": "05/02/2021", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIxLzAyLzA1LzMtcmVhc29ucy1pdHMtbm90LXRvby1sYXRlLXRvLWJ1eS12ZXJ0ZXgtcGhhcm1hY2V1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNW5MWFV4T1hSd1pFSktlbkF6VFJDa0FSaXlBaWdCTWdNQkFCUQ=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Zhiyuan Sun", "sentiment": "negative"}, {"title": "Vertex Pharma (VRTX) expands cystic fibrosis pipeline; raises FY21 outlook", "desc": null, "date": "22/11/2021", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vdmVydGV4LXBoYXJtYS12cnR4LWV4cGFuZHMtY3lzdGljLWZpYnJvc2lzLXBpcGVsaW5lLXJhaXNlcy1meTIxLW91dGxvb2sv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUZaRzFYWW5ORU5EQm1WMWgxVFJDVkFoaTJBU2dCTWdrQklZU3pLS2VTa1FF=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "New VRTX Fitness, Apex Bistro features beer, wine and public rooftop deck", "desc": null, "date": "26/04/2021", "link": "news.google.com/articles/CBMimwFodHRwczovL21pc3NvdWxpYW4uY29tL25ld3MvbG9jYWwvbmV3LXZydHgtZml0bmVzcy1hcGV4LWJpc3Ryby1mZWF0dXJlcy1iZWVyLXdpbmUtYW5kLXB1YmxpYy1yb29mdG9wLWRlY2svYXJ0aWNsZV80ZThlNGEzNC1jZGQ1LTU4MTQtYTcyNC01ZmVhOTkwYTk2NDUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNHpaM0puVWsxaFZYVnRjRVJ6VFJDakFSaTJBaWdCTWdtQklJVHJwT1NwOFFB=-w200-h112-p-df", "media": "Missoulian", "site": null, "reporter": "David Erickson", "sentiment": "positive"}, {"title": "What's Next For Vertex Pharmaceuticals Stock After An 8% Fall Last Week?", "desc": null, "date": "14/06/2021", "link": "news.google.com/articles/CBMiggFodHRwczovL3d3dy50cmVmaXMuY29tL3N0b2NrL3ZydHgvYXJ0aWNsZXMvNTE3NzE3L3doYXRzLW5leHQtZm9yLXZlcnRleC1waGFybWFjZXV0aWNhbHMtc3RvY2stYWZ0ZXItYW4tOC1mYWxsLWxhc3Qtd2Vlay8yMDIxLTA2LTE00gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXJla1ZXVFZGalpuZE1Va0Z4VFJDZUFSakFBaWdCTWdtSkFvcHFpZXhFRXdF=-w200-h112-p-df", "media": "Trefis", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex (VRTX) Initiates Phase II Study on Pain Candidate", "desc": null, "date": "20/07/2021", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtdnJ0eC1pbml0aWF0ZXMtcGhhc2UtaWktMTE0MDExMjAwLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVlaM2xSWlhCNVRGSndXVlpoVFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Seeks Trials of Therapies for Cystic Fibrosis, Diabetes", "desc": null, "date": "02/11/2021", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIxLTExLTAyL3ZlcnRleC1zZWVrcy10cmlhbHMtb2YtdGhlcmFwaWVzLWZvci1jeXN0aWMtZmlicm9zaXMtZGlhYmV0ZXPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNTJiWFJRZWt0a2FXZDRhbFV6VFJDM0FSaVRBaWdCTWdPQndnSQ=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Angelica Peebles", "sentiment": "negative"}, {"title": "Vertex Appoints Stuart A. Arbuckle as Chief Operating Officer", "desc": null, "date": "04/08/2021", "link": "news.google.com/articles/CBMidmh0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMjEwODA0MDA1MTU0L2VuL1ZlcnRleC1BcHBvaW50cy1TdHVhcnQtQS4tQXJidWNrbGUtYXMtQ2hpZWYtT3BlcmF0aW5nLU9mZmljZXLSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNUpaRVpRTVZCR1dXVlVlbTVaVFJDaUFSaTNBaWdCTWdPSllRWQ=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Announces Positive Results From Phase 2 Study of VX-147 in APOL1-Mediated Focal Segmental ...", "desc": null, "date": "01/12/2021", "link": "news.google.com/articles/CBMingFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9yZWxlYXNlcy92ZXJ0ZXgtYW5ub3VuY2VzLXBvc2l0aXZlLXJlc3VsdHMtZnJvbS1waGFzZS0yLXN0dWR5LW9mLXZ4LTE0Ny1pbi1hcG9sMS1tZWRpYXRlZC1mb2NhbC1zZWdtZW50YWwtZ2xvbWVydWxvc2NsZXJvc2lzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXdMVmRvTjNCUFJUWjBXaTFYVFJDVkFSalRBaWdCTWdPWmRnNA=-w200-h112-p-df", "media": "BioSpace", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Will Vertex Pharmaceuticals Stock See Higher Levels?", "desc": null, "date": "10/12/2021", "link": "news.google.com/articles/CBMibmh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMS8xMi8xMC93aWxsLXZlcnRleC1waGFybWFjZXV0aWNhbHMtc3RvY2stc2VlLWhpZ2hlci1sZXZlbHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlNRUZ0ZVc5dlIxOXpkMDFSVFJEQ0FSaURBaWdCTWdZUllZQUpzUWM=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Rethinking education and the future of work", "desc": null, "date": "16/09/2021", "link": "news.google.com/articles/CBMiQmh0dHBzOi8vd3d3LnZydHguY29tL3N0b3JpZXMvcmV0aGlua2luZy1lZHVjYXRpb24tYW5kLWZ1dHVyZS13b3JrL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlaVXhLVUVnd04xVldaalZ6VFJERkFSaUFBaWdCTWdhQlk0empxUWM=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Pharmaceuticals Stock Shows Every Sign Of Being Significantly Undervalued", "desc": null, "date": "06/06/2021", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXN0b2NrLXNob3dzLWV2ZXJ5LTAyMDAxNTE5MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVpNbTVyWkVwNFdERmlSRkF0VFJDdUFSaWlBaWdCTWdZQkE0b2lDdzA=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Why Vertex Pharmaceuticals Stock Is Getting Hammered Today", "desc": null, "date": "11/06/2021", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIxLzA2LzExL3doeS12ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXN0b2NrLWlzLWdldHRpbmctaGFtbWVyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDVURlJCTXpOc1drNDBXamQwVFJDakFSaTJBaWdCTWdZUmdZUzFzQVE=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "George Budwell", "sentiment": "negative"}, {"title": "Investing in the future: A conversation with Vertex and Year Up | Vertex", "desc": null, "date": "16/09/2021", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vd3d3LnZydHguY29tL2VuLXVzL3N0b3JpZXMvaW52ZXN0aW5nLWZ1dHVyZS1jb252ZXJzYXRpb24tdmVydGV4LWFuZC15ZWFyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdZM1JsT0dOdVJYSnVUblJxVFJDM0FSaVRBaWdCTWdZaGNKTEtMUWc=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Could Vertex Pharmaceuticals Be a Prime Acquisition Target?", "desc": null, "date": "01/07/2021", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIxLzA3LzAxL2NvdWxkLXZlcnRleC1waGFybWFjZXV0aWNhbHMtYmUtYS1wcmltZS1hY3F1aXNpdGlvL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXNiM0o0TkZobFpqa3dabTF6VFJDb0FSaXNBaWdCTWdZRllaREhyQWM=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Keith Speights & Brian Orelli", "sentiment": "negative"}, {"title": "Virtual onboarding: Lessons learned at Vertex | Vertex", "desc": null, "date": "07/01/2021", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vd3d3LnZydHguY29tL2VuLXVzL3N0b3JpZXMvdmlydHVhbC1vbmJvYXJkaW5nLWxlc3NvbnMtbGVhcm5lZC12ZXJ0ZXgv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDRjRFpuYTNseVFUUkxlVnBaVFJDM0FSaVRBaWdCTWdZTmNvd1JRUVU=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Concert Pharmaceuticals Announces Sale of VX-561 Milestones to Vertex for $32 Million", "desc": null, "date": "17/05/2021", "link": "news.google.com/articles/CBMijQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDUxNzAwNTgzOC9lbi9Db25jZXJ0LVBoYXJtYWNldXRpY2Fscy1Bbm5vdW5jZXMtU2FsZS1vZi1WWC01NjEtTWlsZXN0b25lcy10by1WZXJ0ZXgtZm9yLTMyLU1pbGxpb27SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUdXVGxoVW01NVIwcEZXVmREVFJDaUFSaTNBaWdCTWdZQmNJclJzQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex and Arbor Biotechnologies Establish New Partnership to Develop Novel ex vivo Engineered Cell Therapies", "desc": null, "date": "24/08/2021", "link": "news.google.com/articles/CBMitQFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMS8wOC8yNC8yMjg1MzkyLzAvZW4vVmVydGV4LWFuZC1BcmJvci1CaW90ZWNobm9sb2dpZXMtRXN0YWJsaXNoLU5ldy1QYXJ0bmVyc2hpcC10by1EZXZlbG9wLU5vdmVsLWV4LXZpdm8tRW5naW5lZXJlZC1DZWxsLVRoZXJhcGllcy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUpTbkJFWTFJNE5FMHRRazlOVFJEaEFSamhBU2dCTWdZWnNveExSUVU=-w200-h112-p-df", "media": "GlobeNewswire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Pharmaceuticals Stock Is Believed To Be Possible Value Trap", "desc": null, "date": "29/03/2021", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXN0b2NrLWJlbGlldmVkLXBvc3NpYmxlLTA1MTIyMzMyNS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVZTakJZU3pkc2FtSkVlVlEyVFJDdUFSaWlBaWdCTWdNQkF3Zw=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "About HMP Global", "desc": null, "date": "12/06/2021", "link": "news.google.com/articles/CBMiQ2h0dHBzOi8vd3d3LmhtcGdsb2JhbGxlYXJuaW5nbmV0d29yay5jb20vYWJvdXQtaG1wLWxlYXJuaW5nLW5ldHdvcmvSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iKkNnNHRja3RrVW1ZMmVFcG1iVGwyVFJCOUdKSURLQUV5QnJremlqR2RCdw=-w200-h112-p-df", "media": "hmpgloballearningnetwork.com", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Pharmaceuticals Inc. stock falls Monday, underperforms market", "desc": null, "date": "27/12/2021", "link": "news.google.com/articles/CBMihQFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vYW1wL2RhdGEtbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLWluYy1zdG9jay1mYWxscy1tb25kYXktdW5kZXJwZXJmb3Jtcy1tYXJrZXQtMDE2NDA2NDQyMTEtNTg2ZDk3ZWQ3NWMw0gGFAWh0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9hbXAvZGF0YS1uZXdzL3ZlcnRleC1waGFybWFjZXV0aWNhbHMtaW5jLXN0b2NrLWZhbGxzLW1vbmRheS11bmRlcnBlcmZvcm1zLW1hcmtldC0wMTY0MDY0NDIxMS01ODZkOTdlZDc1YzA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURiR1JPYVZjMlFpMVJNMUpWVFJEaEFSamdBU2dCTWdZRllKQ0tzQWM=-w200-h112-p-df", "media": "MarketWatch", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex and Obsidian Therapeutics Establish Collaboration to Discover Novel Therapies That Regulate Gene Editing", "desc": null, "date": "22/04/2021", "link": "news.google.com/articles/CBMiqAFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDQyMjAwNTEwNi9lbi9WZXJ0ZXgtYW5kLU9ic2lkaWFuLVRoZXJhcGV1dGljcy1Fc3RhYmxpc2gtQ29sbGFib3JhdGlvbi10by1EaXNjb3Zlci1Ob3ZlbC1UaGVyYXBpZXMtVGhhdC1SZWd1bGF0ZS1HZW5lLUVkaXRpbmfSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURkMVJ1V1RNeWRIY3hhRlJyVFJDMkFSaVVBaWdCTWdZRmNZQUl2UVk=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "These Stocks Can Offer Higher Returns Compared To Abbott Labs", "desc": null, "date": "05/03/2021", "link": "news.google.com/articles/CBMieGh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMS8wMy8wNS90aGVzZS1zdG9ja3MtY2FuLW9mZmVyLWhpZ2hlci1yZXR1cm5zLWNvbXBhcmVkLXRvLWFiYm90dC1sYWJzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXBiekJKVjJsRlpFVXpZWGgyVFJEQ0FSaURBaWdCTWdZWjVZQXF6Z0U=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Stranded killer whale baby had just as high levels of toxic chemicals as adults - English articles", "desc": null, "date": "19/05/2021", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LnRpdGFuLnVpby5uby9lbmdsaXNoLzIwMjEvc3RyYW5kZWQta2lsbGVyLXdoYWxlLWJhYnktaGFkLWp1c3QtaGlnaC1sZXZlbHMtdG94aWMtY2hlbWljYWxzLWFkdWx0cy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlhSHA0ZUZVNFR6ZE1ZMDVaVFJDM0FSaVRBaWdCTWdZQk1JUmt6QU0=-w200-h112-p-df", "media": "Universitetet i Oslo", "site": null, "reporter": "Eivind Torgersen", "sentiment": "negative"}, {"title": "Vertex Announces Primary Endpoint Achieved in Phase 2 Study of VX-864 in Alpha-1 Antitrypsin Deficiency", "desc": null, "date": "10/06/2021", "link": "news.google.com/articles/CBMioAFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDYxMDAwNTkzOS9lbi9WZXJ0ZXgtQW5ub3VuY2VzLVByaW1hcnktRW5kcG9pbnQtQWNoaWV2ZWQtaW4tUGhhc2UtMi1TdHVkeS1vZi1WWC04NjQtaW4tQWxwaGEtMS1BbnRpdHJ5cHNpbi1EZWZpY2llbmN50gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iKkNnNTNUMjlTUmpodU5XWlZkR3RVVFJCMkdLc0RLQUV5Qm9FU2xNa1FDdw=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Photos of Adrianne Lenker at Wonder Ballroom on Dec. 4, 2021", "desc": null, "date": "04/12/2021", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2Fkcmlhbm5lLWxlbmtlci1hdC13b25kZXItYmFsbHJvb20tb24tZGVjLTQtMjAyMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVRkemhmVVhSNlRrTkRkV2h4VFJDM0FSaVRBaWdCTWdhNUk0NVJGUW8=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Ignacio Quintana", "sentiment": "positive"}, {"title": "Evelo (EVLO) Posts Positive Data from Phase II Psoriasis Study", "desc": null, "date": "28/09/2021", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvZXZlbG8tZXZsby1wb3N0cy1wb3NpdGl2ZS1kYXRhLTE2MzEwNDgzNy5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXZUMlpMVm1sTk4zaG5RMDlwVFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Photos of Cory Wong at Wonder Ballroom on Nov. 9, 2021", "desc": null, "date": "09/11/2021", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2Nvcnktd29uZy1hdC13b25kZXItYmFsbHJvb20tb24tbm92LTktMjAyMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVFNRUZ5VG5kTExUSTFkazFWVFJDM0FSaVRBaWdCTWdrQm9vaEZ1U1NwVFFJ=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Andrew Julius Wallner", "sentiment": "positive"}, {"title": "TECHIIA holding invests in Culver Aviation, Ukraine's UAV pioneer getting ready to go global", "desc": null, "date": "02/06/2021", "link": "news.google.com/articles/CBMigAFodHRwczovL2VtZXJnaW5nLWV1cm9wZS5jb20vYnVzaW5lc3MvdGVjaGlpYS1ob2xkaW5nLWludmVzdHMtaW4tY3VsdmVyLWF2aWF0aW9uLXVrcmFpbmVzLXVhdi1waW9uZWVyLWdldHRpbmctcmVhZHktdG8tZ28tZ2xvYmFsL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXhSRFpYTjNSUmNXeHpRamxQVFJDb0FSaXNBaWdCTWdZbGhKU3RNUWM=-w200-h112-p-df", "media": "Emerging Europe", "site": null, "reporter": "Marek Grzegorczyk", "sentiment": "positive"}, {"title": "Lightning Round Stocks to Buy From 'Mad Money' With Jim Cramer", "desc": null, "date": "17/02/2021", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vamltLWNyYW1lci9saWdodG5pbmctcm91bmQtc3RvY2tzLXRvLWJ1eS1mcm9tLW1hZC1tb25leS13aXRoLWppbS1jcmFtZXLSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXNjbFJUTVVSdGQzZzNlVGRpVFJDb0FSaXJBaWdCTWdZWmhKRHBOUVk=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Danny Peterson", "sentiment": "negative"}, {"title": "Bristol Myers' (BMY) sBLA for Orencia Gets FDA Priority Review", "desc": null, "date": "24/08/2021", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vdWsubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2JyaXN0b2wtbXllcnMtYm15LXNibGEtb3JlbmNpYS0xNjQxMDQxMjEuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWhiVlZqWkdKQ2RXSnRUM0JJVFJDckFSaW1BaWdCTWdZSkFwSW5KUWc=-w200-h112-p-df", "media": "Yahoo News UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "NASA Struggles to Fix Failure of Hubble Space Telescope's 1980s Computer", "desc": null, "date": "19/06/2021", "link": "news.google.com/articles/CBMiZWh0dHBzOi8vc2NpdGVjaGRhaWx5LmNvbS9uYXNhLXN0cnVnZ2xlcy10by1maXgtZmFpbHVyZS1vZi1odWJibGUtc3BhY2UtdGVsZXNjb3Blcy0xOTgwcy1jb21wdXRlci9hbXAv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXdPV2gxUWxwMFZHSjNVVGhwVFJDM0FSaVVBaWdCTWdrSlFJUzJHT214VVFF=-w200-h112-p-df", "media": "SciTechDaily", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "MA-VERTEX-PHARMA | Business Wire", "desc": null, "date": "19/10/2021", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vdmlhLnJpdHphdS5kay9wcmVzc2VtZWRkZWxlbHNlLzEzNjM0MDMyL21hLXZlcnRleC1waGFybWE_cHVibGlzaGVySWQ9OTA0NTbSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUxSekZuYzFZemRHcEVhVmxEVFJDaUFSaTNBaWdCTWdZTm9wVG5PQWM=-w200-h112-p-df", "media": "Via Ritzau", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Newcastle students recognised as Trailblazers", "desc": null, "date": "28/12/2021", "link": "news.google.com/articles/CBMimAFodHRwczovL3d3dy5kYWlseXRlbGVncmFwaC5jb20uYXUvbmV3c2xvY2FsL3RoZS1uZXdjYXN0bGUtbmV3cy9uZXdjYXN0bGUtc3R1ZGVudHMtcmVjb2duaXNlZC1hcy10cmFpbGJsYXplcnMvbmV3cy1zdG9yeS8wOTM4MjlmMzY1YTZlZDQ0YmM1MDEyYmY5YWZlYzljZtIBnAFodHRwczovL3d3dy5kYWlseXRlbGVncmFwaC5jb20uYXUvbmV3c2xvY2FsL3RoZS1uZXdjYXN0bGUtbmV3cy9uZXdjYXN0bGUtc3R1ZGVudHMtcmVjb2duaXNlZC1hcy10cmFpbGJsYXplcnMvbmV3cy1zdG9yeS8wOTM4MjlmMzY1YTZlZDQ0YmM1MDEyYmY5YWZlYzljZj9hbXA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFOWE0xU0cxcWVrOUdMVkJMVFJDb0FSaXNBaWdCTWdZcEpvYnRtUWs=-w200-h112-p-df", "media": "Newcastle News", "site": null, "reporter": "Cassandra Baldini", "sentiment": "positive"}, {"title": "Careers | Career Growth and Opportunities", "desc": null, "date": "23/06/2022", "link": "news.google.com/articles/CBMiPWh0dHBzOi8vd3d3LnZydHguY29tL2NhcmVlcnMvY2FyZWVyLWdyb3d0aC1hbmQtb3Bwb3J0dW5pdGllcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhSSGgzZVZFMGNuVXRjMUZPVFJEaEFSamhBU2dCTWdZMVU1WlJvUWc=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "What's Driving Vertex Pharmaceuticals Stock Higher?", "desc": null, "date": "29/09/2022", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMi8wOS8yOS93aGF0cy1kcml2aW5nLXZlcnRleC1waGFybWFjZXV0aWNhbHMtc3RvY2staGlnaGVyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlNRUZ0ZVc5dlIxOXpkMDFSVFJEQ0FSaURBaWdCTWdZUllZQUpzUWM=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex (VRTX) VX-880 Early Study Sees Lifting of Clinical Hold", "desc": null, "date": "06/07/2022", "link": "news.google.com/articles/CBMiRmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtdnJ0eC12eC04ODAtZWFybHktMTQ1MjAyMDg0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVlaM2xSWlhCNVRGSndXVlpoVFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Falls After FDA Halts Diabetes Study in Surprise Move (2)", "desc": null, "date": "02/05/2022", "link": "news.google.com/articles/CBMicGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIyLTA1LTAyL3ZlcnRleC1mYWxscy1hZnRlci1mZGEtcGF1c2VzLWRpYWJldGVzLXN0dWR5LWluLXN1cnByaXNlLW1vdmXSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTNjSGd0ZUZKYVRrTTBkV2R1VFJDMkFSaVZBaWdCTWdhSmNvck5NUVk=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Catherine Larkin & Ike Swetlitz", "sentiment": "negative"}, {"title": "What competition? Vertex touts Trikafta's competitive edge on back of strong 2021", "desc": null, "date": "27/01/2022", "link": "news.google.com/articles/CBMibmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3doYXQtY29tcGV0aXRpb24tdmVydGV4LXRvdXRzLXRyaWthZnRhLXMtY29tcGV0aXRpdmUtZWRnZS1iYWNrLXN0cm9uZy0yMDIx0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUVMVmRYTFc1U1NVaHljbmszVFJETkFSajJBU2dCTWdZdEJaNnVqUW8=-w200-h112-p-df", "media": "FiercePharma", "site": null, "reporter": "Fraiser Kansteiner", "sentiment": "negative"}, {"title": "Where Will Vertex Pharmaceuticals Be in 5 Years?", "desc": null, "date": "25/04/2022", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzA0LzI1L3doZXJlLXdpbGwtdmVydGV4LXBoYXJtYWNldXRpY2Fscy1iZS1pbi01LXllYXJzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUZSRVZDUzNoTlVrZ3pOR05rVFJDM0FSaVRBaWdCTWdtSklaaldqR3U1aUFJ=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Alex Carchidi", "sentiment": "positive"}, {"title": "Responsibility | Reports, Position Statements and Policies", "desc": null, "date": "23/06/2022", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vd3d3LnZydHguY29tL3Jlc3BvbnNpYmlsaXR5L3JlcG9ydHMtcG9zaXRpb24tc3RhdGVtZW50cy1hbmQtcG9saWNpZXMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDRSa2hPTTJweFUwb3pRV2hpVFJEaEFSamhBU2dCTWdZZEE1Wk1qUW8=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Where Will Vertex Pharmaceuticals Be in 10 Years?", "desc": null, "date": "18/12/2022", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzEyLzE4L3doZXJlLXdpbGwtdmVydGV4LXBoYXJtYWNldXRpY2Fscy1iZS1pbi0xMC15ZWFycy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXJXbkZDZFVGWFRXbEJjV053VFJDM0FSaVRBaWdCTWdZdE5aTE9uUWs=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Alex Carchidi", "sentiment": "positive"}, {"title": "Vertex's inclusion, diversity and equity priorities | Vertex", "desc": null, "date": "05/07/2022", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vd3d3LnZydHguY29tL2VuLXVzL3N0b3JpZXMvdmVydGV4cy1pbmNsdXNpb24tZGl2ZXJzaXR5LWFuZC1lcXVpdHktcHJpb3JpdGllcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNHpaQzFNYTJGak5tNVdUblJLVFJDU0FSalpBaWdCTWdrQklJcURIR2Nza2dF=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Is Vertex Pharmaceuticals About to Become a Dividend Stock?", "desc": null, "date": "02/11/2022", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzExLzAyL3ZlcnRleC1waGFybWFjZXV0aWNhbHMtYWJvdXQtdG8tYmUtZGl2aWRlbmQtc3RvY2sv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVXRE5PVkZCSFlUVnFWVk51VFJDckFSaW1BaWdCTWdZMWM0Z3lLUWM=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Keith Speights", "sentiment": "negative"}, {"title": "Targeting the Toughest Diseases Podcast", "desc": null, "date": "06/12/2022", "link": "news.google.com/articles/CBMiPWh0dHBzOi8vd3d3LnZydHguY29tL291ci1zY2llbmNlL3RhcmdldGluZy10b3VnaGVzdC1kaXNlYXNlcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXRSQzA1Y1ZGMk1FcHphMHB4VFJEaEFSamhBU2dCTWdhaEU0Nk9FUXM=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Careers | Benefits", "desc": null, "date": "23/06/2022", "link": "news.google.com/articles/CBMiJmh0dHBzOi8vd3d3LnZydHguY29tL2NhcmVlcnMvYmVuZWZpdHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUtaRTVIVlVjd2RGVkdTbVpmVFJEaEFSamhBU2dCTWdrTlU1SXlIYW1wclFF=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Innovation is our lifeblood | Vertex", "desc": null, "date": "13/06/2022", "link": "news.google.com/articles/CBMiNmh0dHBzOi8vd3d3LnZydHguY29tL3N0b3JpZXMvaW5ub3ZhdGlvbi1vdXItbGlmZWJsb29kL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWFiRFpFVFRadU1uSldXR2Q2VFJERkFSaUFBaWdCTWdhOWNaVFZMQWM=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Meet some of the women on Vertex's DMD team", "desc": null, "date": "22/09/2022", "link": "news.google.com/articles/CBMiPmh0dHBzOi8vd3d3LnZydHguY29tL3N0b3JpZXMvbWVldC1zb21lLXdvbWVuLXZlcnRleHMtZG1kLXRlYW0v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFSVEEwTVUxUE5rVmtXVkE1VFJERkFSaUFBaWdCTWdZQk1aempvUWs=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "My life's mission: Pursuing innovative ways to manage pain", "desc": null, "date": "27/09/2022", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vd3d3LnZydHguY29tL3N0b3JpZXMvbXktbGlmZXMtbWlzc2lvbi1wdXJzdWluZy1pbm5vdmF0aXZlLXdheXMtbWFuYWdlLXBhaW4v0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXFNMWs0U1hWSGRsWmZZMFZFVFJERkFSaUFBaWdCTWdZdFJaS3VIUWs=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Patients | APOL1-Mediated Kidney Disease", "desc": null, "date": "24/07/2022", "link": "news.google.com/articles/CBMiPGh0dHBzOi8vd3d3LnZydHguY29tL3BhdGllbnRzL2Fwb2wxLW1lZGlhdGVkLWtpZG5leS1kaXNlYXNlL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW5RWEpvVXpVMVVFcEhUR0ZpVFJEaEFSamhBU2dCTWdhbEpZVE1sUWs=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Announces Statistically Significant and Clinically Meaningful Results From Two Phase 2 Proof-of-Concept ...", "desc": null, "date": "31/03/2022", "link": "news.google.com/articles/CBMi2QFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMDMzMDAwNTk2My9lbi9WZXJ0ZXgtQW5ub3VuY2VzLVN0YXRpc3RpY2FsbHktU2lnbmlmaWNhbnQtYW5kLUNsaW5pY2FsbHktTWVhbmluZ2Z1bC1SZXN1bHRzLUZyb20tVHdvLVBoYXNlLTItUHJvb2Ytb2YtQ29uY2VwdC1TdHVkaWVzLW9mLVZYLTU0OC1mb3ItdGhlLVRyZWF0bWVudC1vZi1BY3V0ZS1QYWlu0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Patients | Beta Thalassemia", "desc": null, "date": "01/07/2022", "link": "news.google.com/articles/CBMiL2h0dHBzOi8vd3d3LnZydHguY29tL3BhdGllbnRzL2JldGEtdGhhbGFzc2VtaWEv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWtaVFJ3ZVd4eVlVRTVTVVZNVFJEaEFSamhBU2dCTWdhUmc1S01NUWM=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta ...", "desc": null, "date": "27/09/2022", "link": "news.google.com/articles/CBMiuwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMDkyNzAwNTQ1NC9lbi9WZXJ0ZXgtYW5kLUNSSVNQUi1UaGVyYXBldXRpY3MtQW5ub3VuY2UtR2xvYmFsLWV4YS1jZWwtUmVndWxhdG9yeS1TdWJtaXNzaW9ucy1mb3ItU2lja2xlLUNlbGwtRGlzZWFzZS1hbmQtQmV0YS1UaGFsYXNzZW1pYS1pbi0yMDIy0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNUpaRVpRTVZCR1dXVlVlbTVaVFJDaUFSaTNBaWdCTWdPSllRWQ=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Avoiding Big Losses Means Some Small Losses", "desc": null, "date": "10/06/2022", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vcmVzZWFyY2gvc3dpbmctdHJhZGluZy9zbWFsbC1sb3NzLWluLXZydHgtc3RvY2stYXZvaWRlZC1sYXJnZS1sb3NzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVRjV0V5YkhSMlVrcE9VVU5PVFJDcEFSaXJBaWdCTWdNUkFCSQ=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Justin Nielsen", "sentiment": "negative"}, {"title": "Patients | Sickle Cell Disease", "desc": null, "date": "23/06/2022", "link": "news.google.com/articles/CBMiMmh0dHBzOi8vd3d3LnZydHguY29tL3BhdGllbnRzL3NpY2tsZS1jZWxsLWRpc2Vhc2Uv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXNlRWhTY0U5MFQwODVVMWhNVFJEaEFSamhBU2dCTWdtUkU0NVJEZXVoelFF=-w200-h112-p-df", "media": "Vertex Newsroom", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "NASDAQ Stocks For The Santa Claus Rally", "desc": null, "date": "13/12/2022", "link": "news.google.com/articles/CBMiYmh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMi8xMi8xMy9uYXNkYXEtc3RvY2tzLWZvci10aGUtc2FudGEtY2xhdXMtcmFsbHkv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpaREpZVEdOWFdHdEZWM2xKVFJDM0FSaVRBaWdCTWdZeGdZZ1d0UVk=-w200-h112-p-df", "media": "Forbes", "site": null, "reporter": "Bill Sarubbi", "sentiment": "negative"}, {"title": "Biotech Stock Roundup: REGN, VRTX Earnings Update, BHVN Up on Regulatory News", "desc": null, "date": "12/05/2022", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vYXUubGlmZXN0eWxlLnlhaG9vLmNvbS9saWZlc3R5bGUvYmlvdGVjaC1zdG9jay1yb3VuZHVwLXJlZ24tdnJ0eC0xMzExMDEwMjMuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVZjWGQ0VUVWS2RUQXRlbnBGVFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Lifestyle Australia", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Suketu Upadhyay Elected to Vertex Board of Directors", "desc": null, "date": "18/05/2022", "link": "news.google.com/articles/CBMibWh0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMjIwNTE4MDA1MjAxL2VuL1N1a2V0dS1VcGFkaHlheS1FbGVjdGVkLXRvLVZlcnRleC1Cb2FyZC1vZi1EaXJlY3RvcnPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vortex Energy Corp. to Begin Trading on the Canadian Securities Exchange Under the Symbol \u201cVRTX\u201d on December ...", "desc": null, "date": "28/12/2022", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92b3J0ZXgtZW5lcmd5LWNvcnAtYmVnaW4tdHJhZGluZy0xMzAwMDA3MzUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iIkNnNXVhMlZVZWpVMlNFbFNiWHBHVFJCMUdLd0NLQUV5QUE=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex and Verve Therapeutics Establish Collaboration to Discover and Develop an In Vivo Gene Editing Program for ...", "desc": null, "date": "20/07/2022", "link": "news.google.com/articles/CBMixwFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMi8wNy8yMC8yNDgzMTQxLzAvZW4vVmVydGV4LWFuZC1WZXJ2ZS1UaGVyYXBldXRpY3MtRXN0YWJsaXNoLUNvbGxhYm9yYXRpb24tdG8tRGlzY292ZXItYW5kLURldmVsb3AtYW4tSW4tVml2by1HZW5lLUVkaXRpbmctUHJvZ3JhbS1mb3ItTGl2ZXItRGlzZWFzZS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWxUMHN5YlU5aVFYZElWSEI2VFJDaUFSaXNBaWdCTWdZQlVJYUYwZ1E=-w200-h112-p-df", "media": "GlobeNewswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "ATHA: Forget Athira Pharma, Pick Up These 4 Top-Rated Biotech Stocks Instead", "desc": null, "date": "06/07/2022", "link": "news.google.com/articles/CBMic2h0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2F0aGEtdnJ0eC1hbWduLXV0aHItc2JobXktZm9yZ2V0LWF0aGlyYS1waGFybWEtcGljay11cC10aGVzZS00LXRvcC1yYXRlZC1iaW90ZWNoLXN0b2Nrcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVVSV1pXVEdSUVFXaHRiazUzVFJDM0FSaVRBaWdCTWdZRllwQUdNUWM=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Sweta Vijayan", "sentiment": "negative"}, {"title": "Vertex Announces Partnership with Basketball Hall-of-Famer Alonzo Mourning to Raise Awareness of APOL1 ...", "desc": null, "date": "04/11/2022", "link": "news.google.com/articles/CBMivAFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMTEwNDAwNTE4Ni9lbi9WZXJ0ZXgtQW5ub3VuY2VzLVBhcnRuZXJzaGlwLXdpdGgtQmFza2V0YmFsbC1IYWxsLW9mLUZhbWVyLUFsb256by1Nb3VybmluZy10by1SYWlzZS1Bd2FyZW5lc3Mtb2YtQVBPTDEtTWVkaWF0ZWQtS2lkbmV5LURpc2Vhc2UtQU1LRNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Is It Too Late to Buy Vertex Pharmaceuticals Stock?", "desc": null, "date": "06/12/2022", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzEyLzA2L2lzLWl0LXRvby1sYXRlLXRvLWJ1eS12ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXN0b2NrL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTBTVWxOY25aUWRrTktaRU5XVFJDeEFSaWNBaWdCTWdrQkFwVGpncTFNcVFJ=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated Kidney Disease", "desc": null, "date": "22/03/2022", "link": "news.google.com/articles/CBMinwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMDMyMTAwNTkzOS9lbi9WZXJ0ZXgtQWR2YW5jZXMtVlgtMTQ3LUludG8tUGl2b3RhbC1DbGluaWNhbC1EZXZlbG9wbWVudC1mb3ItUGVvcGxlLVdpdGgtQVBPTDEtTWVkaWF0ZWQtS2lkbmV5LURpc2Vhc2XSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Announces Investigational New Drug (IND) Application for VX-522, mRNA Therapy for People With Cystic ...", "desc": null, "date": "12/12/2022", "link": "news.google.com/articles/CBMiuQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMTIwODAwNTk3Ny9lbi9WZXJ0ZXgtQW5ub3VuY2VzLUludmVzdGlnYXRpb25hbC1OZXctRHJ1Zy1JTkQtQXBwbGljYXRpb24tZm9yLVZYLTUyMi1tUk5BLVRoZXJhcHktZm9yLVBlb3BsZS1XaXRoLUN5c3RpYy1GaWJyb3Npcy1DbGVhcmVkLWJ5LUZEQdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJkNnNU5TVmxmWVcxV1NIWlFZbGhZVFJDUUF4aHBLQUV5QXhVRENn=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Has a Pain Pill That May Replace Opioids", "desc": null, "date": "01/04/2022", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vdGVjaG5vbG9neS92ZXJ0ZXgtaGFzLWEtcGFpbi1waWxsLXRoYXQtbWF5LXJlcGxhY2Utb3Bpb2lkc9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDVZa1ZUVmxsNVUyWnZjMVZmVFJEQ0FSaURBaWdCTWdaSllKUjRxQWM=-w200-h112-p-df", "media": "TheStreet", "site": null, "reporter": "Ellen Chang", "sentiment": "negative"}, {"title": "Vertex Announces Inaxaplin (VX-147) Granted Breakthrough Therapy Designation by U.S. FDA and Priority Medicines ...", "desc": null, "date": "08/06/2022", "link": "news.google.com/articles/CBMiwwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMDYwODAwNTE4MS9lbi9WZXJ0ZXgtQW5ub3VuY2VzLUluYXhhcGxpbi1WWC0xNDctR3JhbnRlZC1CcmVha3Rocm91Z2gtVGhlcmFweS1EZXNpZ25hdGlvbi1ieS1VLlMuLUZEQS1hbmQtUHJpb3JpdHktTWVkaWNpbmVzLVBSSU1FLURlc2lnbmF0aW9uLWJ5LXRoZS1FTUHSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV ...", "desc": null, "date": "08/12/2022", "link": "news.google.com/articles/CBMi1AFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMTIwNzAwNTkyNi9lbi9WZXJ0ZXgtYW5kLUVudHJhZGEtVGhlcmFwZXV0aWNzLUVzdGFibGlzaC1Db2xsYWJvcmF0aW9uLXRvLURpc2NvdmVyLWFuZC1EZXZlbG9wLUVuZG9zb21hbC1Fc2NhcGUtVmVoaWNsZS1FRVYtVGhlcmFwZXV0aWNzLWZvci1NeW90b25pYy1EeXN0cm9waHktVHlwZS0xLURNMdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNDRRVFJQZGpkSFoxYzRiMVl5VFJDakFSaTJBaWdCTWdNQllBUQ=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "GBT Stock: Why Pfizer's $5.4 Billion Takeover Is 'Mutually Beneficial'", "desc": null, "date": "08/08/2022", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2didC1zdG9jay1jb250aW51ZXMtcnVuLW9uLXBmaXplci10YWtlb3Zlci_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNDBjVEp0YTFWelMzSnFObWREVFJDb0FSaXNBaWdCTWdtRllKUUVNeWNtekFF=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "Photos of Gracie Abrams at Wonder Ballroom on Mar. 9, 2022", "desc": null, "date": "09/03/2022", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vd3d3LnZydHhtYWcuY29tL21lZGlhL3Bob3RvL2dyYWNpZS1hYnJhbXMtYXQtd29uZGVyLWJhbGxyb29tLW9uLW1hci05LTIwMjIv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdSMDl0TkROMVpYUnFSUzFNVFJDVEFoaTNBU2dCTWdZcGhaS3VMUWM=-w200-h112-p-df", "media": "Vortex Music Magazine", "site": null, "reporter": "Ignacio Quintana", "sentiment": "positive"}, {"title": "Should You Invest in the VanEck Biotech ETF (BBH)?", "desc": null, "date": "10/01/2022", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vYXUubmV3cy55YWhvby5jb20vZmluYW5jZS9uZXdzL2ludmVzdC12YW5lY2stYmlvdGVjaC1ldGYtYmJoLTExMjAxMTA4My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNW9YMEpFWm1Wd1ZqVjVha2s0VFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo News Australia", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Prothena (PRTA) IND Application Gets FDA Clearance for AD", "desc": null, "date": "29/03/2022", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vdWsuc3R5bGUueWFob28uY29tL3N0eWxlL3Byb3RoZW5hLXBydGEtaW5kLWFwcGxpY2F0aW9uLWdldHMtMTU0NDAzMzIwLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDJPRWRVVFRWT2Rrc3lZa0l0VFJDeUFSaWJBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Lifestyle UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "XXII: Is 22nd Century Group a Buy After the FDA Grants Approval to Market its VLN Cigarettes", "desc": null, "date": "05/01/2022", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL3h4aWktdnJ0eC1hbWduLXNiaG15LWlzLTIybmQtY2VudHVyeS1ncm91cC1hLWJ1eS1hZnRlci10aGUtZmRhLWdyYW50cy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVVSV1pXVEdSUVFXaHRiazUzVFJDM0FSaVRBaWdCTWdZRllwQUdNUWM=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Aditi Ganguly", "sentiment": "negative"}, {"title": "What Makes Vertex Pharmaceuticals Incorporated (VRTX) a Unique Investment Opportunity?", "desc": null, "date": "20/09/2023", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9tYWtlcy12ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLWluY29ycG9yYXRlZC12cnR4LTEyNDQxNTQ1OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU1jbU5aV1hnMU9EVkpaazVNVFJDbUFSaXZBaWdCTWdhMUlaTFZsQWs=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Soumya Eswaran", "sentiment": "negative"}, {"title": "VRTX Stock, A Tech Leader, Slouches But Investors Eye Vertex's Late-Stage Pipeline", "desc": null, "date": "07/11/2023", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L3ZydHgtc3RvY2stdmVydGV4LWVhcm5pbmdzLXEzLTIwMjMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWxVRFZpZGxwVVdUTlVXbkp5VFJDcEFSaXJBaWdCTWdZQkU0WndUUU0=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript", "desc": null, "date": "01/08/2023", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmZvb2wuY29tL2Vhcm5pbmdzL2NhbGwtdHJhbnNjcmlwdHMvMjAyMy8wOC8wMS92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtcTItMjAyMy1lYXJuaW5ncy1jYWxsL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJjRVpPUzNoUE5WZzBaVk5vVFJEb0FSalpBU2dCTWdB=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "VRTX: Vertex Pharmaceuticals (VRTX) Post-Earnings Analysis: Is It Time to Buy the Stock?", "desc": null, "date": "10/11/2023", "link": "news.google.com/articles/CBMidWh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL3ZydHgtZ2lsZC1vdHNreS1jb3J0LXZlcnRleC1waGFybWFjZXV0aWNhbHMtdnJ0eC1wb3N0LWVhcm5pbmdzLWFuYWx5c2lzLWlzLWl0LXRpbWUtdG8tYnV5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlWMWhaTm1OR1FrdFNkM013VFJDb0FSaXNBaWdCTWdZbGNJRFVNQVE=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Anushka Dutta", "sentiment": "negative"}, {"title": "Vertex (VRTX) Soars 13.2%: Is Further Upside Left in the Stock?", "desc": null, "date": "14/12/2023", "link": "news.google.com/articles/CBMiRGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtdnJ0eC1zb2Fycy0xMy0yLTExMTIwMDU4My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVRUblZtTjI5NVl5MWFVMnBRVFJEQ0FSaURBaWdCTWdZcFJZN05JUWc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "VRTX Stock Pops On A Beat And Raise; Investors Eye Looming CRISPR Review", "desc": null, "date": "02/08/2023", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L3ZydHgtc3RvY2stdmVydGV4LWVhcm5pbmdzLXEyLTIwMjMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXFla1ppVjBKM0xXWTVNakpwVFJDb0FSaXJBaWdCTWdZWmhwWUtOZ2M=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Call Transcript", "desc": null, "date": "07/11/2023", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmZvb2wuY29tL2Vhcm5pbmdzL2NhbGwtdHJhbnNjcmlwdHMvMjAyMy8xMS8wNy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtcTMtMjAyMy1lYXJuaW5ncy1jYWxsL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJkblJrUTJWR2FqVlRYMHQyVFJEb0FSalpBU2dCTWdB=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know", "desc": null, "date": "28/12/2023", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtYmVhdHMtc3RvY2stMjI1MDE5OTczLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVJObEo1Y2xoMmVEQjZObGw0VFJDM0FSaVRBaWdCTWdZQlFvNXdOUWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Surprising Opportunity Driving Vertex Stock To A Record High", "desc": null, "date": "12/10/2023", "link": "news.google.com/articles/CBMidWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vcmVzZWFyY2gvdGhlLW5ldy1hbWVyaWNhL3ZydHgtc3RvY2stYnJlYWtzLW91dC10by1hLXJlY29yZC1oaWdoLXRoZS1zdXJwcmlzaW5nLW9wcG9ydHVuaXR5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUxSR0kzVTNOMlluZFVOMWx0VFJDb0FSaXNBaWdCTWdZeEVaYVhsQW8=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "positive"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Moves -0.72%: What You Should Know", "desc": null, "date": "20/12/2023", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtc3RvY2stbW92ZXMtMjI0NTIxMjA1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpNWFUxTVVJelkxcExUM2s0VFJDM0FSaVRBaWdCTWdZQmNvb1NyUVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "GSK vs. VRTX: Which Stock Should Value Investors Buy Now?", "desc": null, "date": "04/12/2023", "link": "news.google.com/articles/CBMiRWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9nc2stdnMtdnJ0eC1zdG9jay12YWx1ZS0xNjQwMTE2NzAuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNRVUpQYjJkbFkzbDJlSFYzVFJDakFSaTFBaWdCTWdZZEJKanRFUW8=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Why Is Vertex (VRTX) Down 6.4% Since Last Earnings Report?", "desc": null, "date": "06/12/2023", "link": "news.google.com/articles/CBMiRGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktdmVydGV4LXZydHgtZG93bi02LTE2MzAzNzI1NS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVRUblZtTjI5NVl5MWFVMnBRVFJEQ0FSaURBaWdCTWdZcFJZN05JUWc=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (NASDAQ:VRTX) shareholders have earned a 14% CAGR over the last five years", "desc": null, "date": "28/11/2023", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLW5hc2RhcS12cnR4LXNoYXJlaG9sZGVycy0xMjAwMjE2MDYuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlXVk5wU214VVkweGpjVWgwVFJDSEFSajJBaWdCTWdZdE5JeHdIUWs=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q3 2023 Earnings Call Transcript", "desc": null, "date": "07/11/2023", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLWluY29ycG9yYXRlZC1uYXNkYXEtdnJ0eC0xNjEzMzk1MDMuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW5iVTVUU0ZWMFptcFZkMWhpVFJDb0FSaXNBaWdCTWdZQlVJd3ZQUVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Insider Monkey", "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: Should You Buy?", "desc": null, "date": "30/10/2023", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtZXhwZWN0ZWQtYmVhdC0xNDAwNDIyMDguaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDNXbVoyT1RoRmNuaEhWVWRNVFJESUFSajlBU2dCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Insider Sell: CEO Reshma Kewalramani Offloads 5,098 Shares of Vertex Pharmaceuticals Inc (VRTX)", "desc": null, "date": "16/12/2023", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9pbnNpZGVyLXNlbGwtY2VvLXJlc2htYS1rZXdhbHJhbWFuaS0wMDAxNTEyMjUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlWMVF0VDJoWlRERTJRV281VFJEaEFSamhBU2dCTWdhWms1QnFOUVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Pharmaceuticals Inc (VRTX) Reports 6% Increase in Q3 2023 Product Revenue", "desc": null, "date": "06/11/2023", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLWluYy12cnR4LXJlcG9ydHMtMjE1NDQ0NzQ5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVNSVzlMWkRKS1dUQmxTRGhvVFJEaEFSamhBU2dCTWdZVms1QktOUVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Biotech Stock Roundup: BLUE, CRSP & VRTX Get Gene Therapy Nod, ACAD Up on Patent News", "desc": null, "date": "14/12/2023", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW90ZWNoLXN0b2NrLXJvdW5kdXAtYmx1ZS1jcnNwLTE0NTUwMDk2OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXBPRkZuUkZkNlYzZFlZMGhoVFJDeUFSaWJBaWdCTWdNTlVnWQ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "The Vertex Pharmaceuticals Inc (VRTX) Company: A Short SWOT Analysis", "desc": null, "date": "08/11/2023", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLWluYy12cnR4LWNvbXBhbnktMDUwODUzMTA4Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTZVRWt5Wm5ORWVuTkROa3hWVFJEaEFSamhBU2dCTWdhWms1QnFOUVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biotech Stock Roundup: BMY's Drug Approval, VRTX & CRSP Gene Therapy Get MHRA Nod", "desc": null, "date": "16/11/2023", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW90ZWNoLXN0b2NrLXJvdW5kdXAtYm15cy1kcnVnLTE1MzAwMDU3Mi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlkbTVSYTBsVGNuUmhhaTFoVFJDeUFSaWJBaWdCTWdhMVFZWXlwUWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex (VRTX) Hits Record High on Non-Opioid Pain Drug Data", "desc": null, "date": "14/12/2023", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtdnJ0eC1oaXRzLXJlY29yZC1oaWdoLTEzMTcwMDk1Mi5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZUMlpMVm1sTk4zaG5RMDlwVFJDeUFSaWJBaWdCTWdhUmNZaUlwZ2c=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Breaks Out To Record High As It Takes On Opioids", "desc": null, "date": "13/12/2023", "link": "news.google.com/articles/CBMiemh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L3ZydHgtc3RvY2stYnJlYWtzLW91dC10by1hLXJlY29yZC1oaWdoLWFzLWl0LXRha2VzLW9uLW9waW9pZHMtaW4tcGFpbi10cmVhdG1lbnQv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXFla1ppVjBKM0xXWTVNakpwVFJDb0FSaXJBaWdCTWdZWmhwWUtOZ2M=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "Is Vertex Pharmaceuticals Stock a Buy Now?", "desc": null, "date": "16/11/2023", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzExLzE2L2lzLXZlcnRleC1waGFybWFjZXV0aWNhbHMtc3RvY2stYS1idXktbm93L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5RblkyVldOWlgzRkdObXhMVFJDM0FSaVRBaWdCTWdhbFVvb1RwUWc=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Q1 2023 Earnings Call Transcript", "desc": null, "date": "01/05/2023", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmZvb2wuY29tL2Vhcm5pbmdzL2NhbGwtdHJhbnNjcmlwdHMvMjAyMy8wNS8wMS92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtcTEtMjAyMy1lYXJuaW5ncy1jYWxsL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJkblJrUTJWR2FqVlRYMHQyVFJEb0FSalpBU2dCTWdB=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Is It Worth Investing in Vertex (VRTX) Based on Wall Street's Bullish Views?", "desc": null, "date": "06/11/2023", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93b3J0aC1pbnZlc3RpbmctdmVydGV4LXZydHgtYmFzZWQtMTQzMDA2Nzg1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNWpSR05NWkdScVNWWllVRE10VFJDM0FSaVRBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Cramer says Vertex has a drug that may address the 'largest market opportunity in the world'", "desc": null, "date": "09/10/2023", "link": "news.google.com/articles/CBMif2h0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjMvMTAvMDkvY3JhbWVyLXNheXMtdmVydGV4LWhhcy1hLWRydWctdGhhdC1tYXktYWRkcmVzcy10aGUtbGFyZ2VzdC1tYXJrZXQtb3Bwb3J0dW5pdHktaW4tdGhlLXdvcmxkLmh0bWzSAYMBaHR0cHM6Ly93d3cuY25iYy5jb20vYW1wLzIwMjMvMTAvMDkvY3JhbWVyLXNheXMtdmVydGV4LWhhcy1hLWRydWctdGhhdC1tYXktYWRkcmVzcy10aGUtbGFyZ2VzdC1tYXJrZXQtb3Bwb3J0dW5pdHktaW4tdGhlLXdvcmxkLmh0bWw?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUJOVFV4VG5od1MyWnJORlJ5VFJDb0FSaXNBaWdCTWdaQkVwNFRGUW8=-w200-h112-p-df", "media": "CNBC", "site": null, "reporter": "Kevin Stankiewicz", "sentiment": "negative"}, {"title": "VRTX Earnings: Highlights of Vertex Pharmaceuticals\u2019 Q3 2023 results", "desc": null, "date": "06/11/2023", "link": "news.google.com/articles/CBMiYGh0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vdnJ0eC1lYXJuaW5ncy1oaWdobGlnaHRzLW9mLXZlcnRleC1waGFybWFjZXV0aWNhbHMtcTMtMjAyMy1yZXN1bHRzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHdWR1JHTlMxQmRGVkdWV3h4VFJDVkFoaTJBU2dCTWdZQkVJU25wQVU=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex (VRTX) Non-Cystic Fibrosis Pipeline Boosts Stock This Year", "desc": null, "date": "21/11/2023", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIxODcwMDMvdmVydGV4LXZydHgtbm9uLWN5c3RpYy1maWJyb3Npcy1waXBlbGluZS1ib29zdHMtc3RvY2stdGhpcy15ZWFy0gFsaHR0cHM6Ly93d3cuemFja3MuY29tL2FtcC9zdG9jay9uZXdzLzIxODcwMDMvdmVydGV4LXZydHgtbm9uLWN5c3RpYy1maWJyb3Npcy1waXBlbGluZS1ib29zdHMtc3RvY2stdGhpcy15ZWFy?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlaM2xSWlhCNVRGSndXVlpoVFJDeUFSaWJBaWdCTWdhWnRaSUpQZ1k=-w200-h112-p-df", "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Stocks making the biggest moves midday: ETSY, PFE, TSLA, VRTX", "desc": null, "date": "13/12/2023", "link": "news.google.com/articles/CBMiXmh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjMvMTIvMTMvc3RvY2tzLW1ha2luZy10aGUtYmlnZ2VzdC1tb3Zlcy1taWRkYXktZXRzeS1wZmUtdHNsYS12cnR4Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXlYM1p2ZEc1cFNWcHZjRmxVVFJDdkFSaWdBaWdCTWdhQlJZek1zUVU=-w200-h112-p-df", "media": "CNBC", "site": null, "reporter": "Samantha Subin", "sentiment": "positive"}, {"title": "Is Vertex Pharmaceuticals Stock a Buy Now?", "desc": null, "date": "15/10/2023", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzEwLzE1L2lzLXZlcnRleC1waGFybWFjZXV0aWNhbHMtc3RvY2stYS1idXktbm93L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNW5OMnROU2pGdWNuVTJhSE16VFJDM0FSaVRBaWdCTWdrQklKNW5IU3JJNWdJ=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "David Jagielski", "sentiment": "negative"}, {"title": "Vertex Stock (NASDAQ:VRTX) Hit a New 52-Week High Yesterday; Here's Why - TipRanks.com", "desc": null, "date": "13/12/2023", "link": "news.google.com/articles/CBMiYGh0dHBzOi8vd3d3LnRpcHJhbmtzLmNvbS9uZXdzL3ZlcnRleC1zdG9jay1uYXNkYXF2cnR4LWhpdC1hLW5ldy01Mi13ZWVrLWhpZ2gteWVzdGVyZGF5LWhlcmVzLXdoedIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWZaREJJUTNCalkxbHdTVTlYVFJDbEFSaXhBaWdCTWdZQnA1QXB2Z1U=-w200-h112-p-df", "media": "TipRanks", "site": null, "reporter": "Radhika Saraogi", "sentiment": "positive"}, {"title": "Vertex Pharmaceuticals (VRTX) Earnings: 2Q23 Key Numbers", "desc": null, "date": "02/08/2023", "link": "news.google.com/articles/CBMiU2h0dHBzOi8vbmV3cy5hbHBoYXN0cmVldC5jb20vdmVydGV4LXBoYXJtYWNldXRpY2Fscy12cnR4LWVhcm5pbmdzLTJxMjMta2V5LW51bWJlcnMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlkV3RyTUhOek1YTlFUa0ZmVFJDVkFoaTJBU2dCTWdZQklZYkdwQVU=-w200-h112-p-df", "media": "AlphaStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals: Shares are Under Heavy Accumulation", "desc": null, "date": "17/12/2023", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXNoYXJlcy11bmRlci1oZWF2eS0xMjEwNDg4MDUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDBhbGN4TTA1YWREbERVakJ2VFJEekFSalFBU2dCTWdZSmtZUXJ1UVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Lucas Downey", "sentiment": "negative"}, {"title": "Vertex Stock Hits Record High on Phase 2 Study Results and Gene-Editing Deal", "desc": null, "date": "13/12/2023", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vdmVydGV4LXN0b2NrLWhpdHMtcmVjb3JkLWhpZ2gtb24tcGhhc2UtMi1zdHVkeS1yZXN1bHRzLWFuZC1nZW5lLWVkaXRpbmctZGVhbC04NDE1NTkz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNU1iV1ZmVjNac2FHVXhORk5CVFJDLUFSaUtBaWdCTWdNQm9BSQ=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Bill McColl", "sentiment": "negative"}, {"title": "Vertex (NASDAQ:VRTX), CRISPR Therapeutics Slip despite Sickle Cell Treatment Approval - TipRanks.com", "desc": null, "date": "08/12/2023", "link": "news.google.com/articles/CBMib2h0dHBzOi8vd3d3LnRpcHJhbmtzLmNvbS9uZXdzL3ZlcnRleC1uYXNkYXF2cnR4LWNyaXNwci10aGVyYXBldXRpY3Mtc2xpcC1kZXNwaXRlLXNpY2tsZS1jZWxsLXRyZWF0bWVudC1hcHByb3ZhbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW9SRlZUYmsxcVdsOHpNbWRFVFJDbEFSaXhBaWdCTWdhVk1aWlFLUWs=-w200-h112-p-df", "media": "TipRanks", "site": null, "reporter": "Vince Condarcuri", "sentiment": "negative"}, {"title": "Vertex (VRTX) Q3 Earnings Beat, Sales Miss, Raises '23 View", "desc": null, "date": "07/11/2023", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvdmVydGV4LXZydHgtcTMtZWFybmluZ3MtYmVhdC1zYWxlcy1taXNzLXJhaXNlcy0yMy12aWV30gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpZMGhuWlVjMFgycHJRbmQ0VFJDcEFSaXFBaWdCTWdZTkFaSU5HUW8=-w200-h112-p-df", "media": "Nasdaq", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "VRTX: 4 A-Rated Biotech Stock Picks for 2024 Success", "desc": null, "date": "26/12/2023", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL3ZydHgtcmVnbi1zZ2lveS11dGhyLTQtYS1yYXRlZC1iaW90ZWNoLXN0b2NrLXBpY2tzLWZvci0yMDI0LXN1Y2Nlc3Mv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTViRVZ6ZWs5Tk4wMXFUVEpzVFJDM0FSaVRBaWdCTWdrQkFJUWxTcUkxQmdJ=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Sristi Suman Jayaswal", "sentiment": "negative"}, {"title": "Midday Movers: Vertex Surges on Gene-Editing Deal, Pfizer Falls on Guidance Miss", "desc": null, "date": "13/12/2023", "link": "news.google.com/articles/CBMic2h0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vbWlkZGF5LW1vdmVycy12ZXJ0ZXgtc3VyZ2VzLW9uLWdlbmUtZWRpdGluZy1kZWFsLXBmaXplci1mYWxscy1vbi1ndWlkYW5jZS1taXNzLTg0MTUzNTfSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtaRk51Y0RoQ2VUSTJlVmx5VFJDM0FSaVRBaWdCTWdZbGNvWVF4UVE=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Bill McColl", "sentiment": "negative"}, {"title": "Is Vertex Pharmaceuticals Stock a Buy Now?", "desc": null, "date": "09/08/2023", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA4LzA5L2lzLXZlcnRleC1waGFybWFjZXV0aWNhbHMtc3RvY2stYS1idXktbm93L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNW5TM2hMYlhGM2FrSnBSbWhPVFJDM0FSaVRBaWdCTWdtWklKcEpKdWd0aGdJ=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Alex Carchidi", "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals: One Chart Explains the Mega Rally", "desc": null, "date": "15/10/2023", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLW9uZS1jaGFydC1leHBsYWlucy0wODQ5MTA3NTcuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVRkUzFsT1U1cFdYWjJTM3BqVFJDM0FSaVRBaWdCTWdZVklvVE5sQW8=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Lucas Downey", "sentiment": "negative"}, {"title": "Vertex (VRTX) Beats on Q4 Earnings & Sales, '23 View Encouraging", "desc": null, "date": "08/02/2023", "link": "news.google.com/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtdnJ0eC1iZWF0cy1xNC1lYXJuaW5ncy0xNTUzMDMzMjQuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXRjbWRDYlZOemRXbDRNRFpGVFJDQ0FSaUVBeWdCTWdhSkFaSkpIUW8=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Better Bull Market Buy: CRISPR Therapeutics or Vertex Pharmaceuticals?", "desc": null, "date": "09/02/2023", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzAyLzA5L2JldHRlci1idWxsLW1hcmtldC1idXktY3Jpc3ByLXRoZXJhcGV1dGljcy12ZXJ0ZXgv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUZaMmRMTjJwV1JXOXVVMDh4VFJDM0FSaVRBaWdCTWdtSk1KWlBwZWd0eGdJ=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Keith Speights", "sentiment": "negative"}, {"title": "Aspen Medical Products Launches First Off-the-Shelf Cervical to Sacrum Spine System", "desc": null, "date": "25/10/2023", "link": "news.google.com/articles/CBMiiwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FzcGVuLW1lZGljYWwtcHJvZHVjdHMtbGF1bmNoZXMtZmlyc3Qtb2ZmLXRoZS1zaGVsZi1jZXJ2aWNhbC10by1zYWNydW0tc3BpbmUtc3lzdGVtLTMwMTk2NzEyOC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNMVEJSVlRabGNERlBOazR0VFJESUFSaklBU2dCTWdhbEJJcXVrUW8=-w200-h112-p-df", "media": "PR Newswire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie", "desc": null, "date": "29/03/2023", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzAzLzI5L2JldHRlci1ncm93dGgtc3RvY2stdmVydGV4LXBoYXJtYWNldXRpY2Fscy1hYmJ2aWUv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWlVSE5XV1ZkU2IyRk9OVEJNVFJDMkFSaVZBaWdCTWdZcE5aS3RtUWs=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Adria Cimino", "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX)'s True Worth: A Complete Analysis of Its Market Value", "desc": null, "date": "14/11/2023", "link": "news.google.com/articles/CBMidmh0dHBzOi8vd3d3Lmd1cnVmb2N1cy5jb20vbmV3cy8yMTIzOTkwL3ZlcnRleC1waGFybWFjZXV0aWNhbHMtdnJ0eHMtdHJ1ZS13b3J0aC1hLWNvbXBsZXRlLWFuYWx5c2lzLW9mLWl0cy1tYXJrZXQtdmFsdWXSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTZVRWt5Wm5ORWVuTkROa3hWVFJEaEFSamhBU2dCTWdhWms1QnFOUVk=-w200-h112-p-df", "media": "GuruFocus.com", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Bitget Lists Wintermute-backed DEX - Vertex (VRTX) Token", "desc": null, "date": "29/11/2023", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vYnJhdmVuZXdjb2luLmNvbS9pbnNpZ2h0cy9iaXRnZXQtbGlzdHMtd2ludGVybXV0ZS1iYWNrZWQtZGV4LXZlcnRleC12cnR4LXRva2Vu0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXhURXRsWkRjeVpEaHRUalJQVFJDdUFSaWlBaWdCTWdrRklaSm10dVl0cmdF=-w200-h112-p-df", "media": "Brave New Coin Insights", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX): A Fairly Valued Stock with Strong Growth Prospects", "desc": null, "date": "02/08/2023", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtZmFpcmx5LXZhbHVlZC0yMzMzMDU5MTIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlWMVF0VDJoWlRERTJRV281VFJEaEFSamhBU2dCTWdhWms1QnFOUVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex, CRISPR Therapeutics Get FDA Approval for First CRISPR Gene-Editing Therapy in US", "desc": null, "date": "08/12/2023", "link": "news.google.com/articles/CBMifGh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vdmVydGV4LWNyaXNwci10aGVyYXBldXRpY3MtZ2V0LWZkYS1hcHByb3ZhbC1mb3ItZmlyc3QtY3Jpc3ByLWdlbmUtZWRpdGluZy10aGVyYXB5LWluLXVzLTg0MTM2NjXSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVhhRW95Vkc4MU0wZzRSemcyVFJDb0FSaXNBaWdCTWdrZGNKaXZ0U2NQS3dJ=-w200-h112-p-df", "media": "Investopedia", "site": null, "reporter": "Bill McColl", "sentiment": "negative"}, {"title": "Better Bet Than WMT Stock: Pay Less Than Walmart To Get More From Stocks VRTX, BSX, AMAT, LOW, QCOM", "desc": null, "date": "14/03/2023", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LnRyZWZpcy5jb20vZGF0YS9jb21wYW5pZXMvV01UL25vLWxvZ2luLXJlcXVpcmVkLzRhTTZxTjBiL0JldHRlci1CZXQtVGhhbi1XTVQtU3RvY2stZ2VuZXJhbC1QZWVyc9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHlOVTR5TkdoMlZqSmlhSFZJVFJDM0FSaVRBaWdCTWdZTkFvak5BUTQ=-w200-h112-p-df", "media": "Trefis", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Announces Publication of VX-548 Positive Phase 2, Proof-of-Concept Results in New England Journal of ...", "desc": null, "date": "03/08/2023", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtYW5ub3VuY2VzLXB1YmxpY2F0aW9uLXZ4LTU0OC0xMjAwMDAyMDYuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURSR1pKVnpVMGNHOTBNemx0VFJDakFSaTJBaWdCTWdZQllJYm0wUVE=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharma: Will VRTX Price Continue Moving Within Wedge Pattern?", "desc": null, "date": "02/11/2023", "link": "news.google.com/articles/CBMibmh0dHBzOi8vdGhlbWFya2V0cGVyaW9kaWNhbC5jb20vMjAyMy8xMS8wMi92ZXJ0ZXgtcGhhcm1hLXdpbGwtdnJ0eC1wcmljZS1jb250aW51ZS1tb3Zpbmctd2l0aGluLXdlZGdlLXBhdHRlcm4v0gFyaHR0cHM6Ly90aGVtYXJrZXRwZXJpb2RpY2FsLmNvbS8yMDIzLzExLzAyL3ZlcnRleC1waGFybWEtd2lsbC12cnR4LXByaWNlLWNvbnRpbnVlLW1vdmluZy13aXRoaW4td2VkZ2UtcGF0dGVybi8_YW1w?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpWV1JuVVVaSlgxQmhlRjlzVFJDb0FSaXNBaWdCTWdZZGNZcE1QUVU=-w200-h112-p-df", "media": "The Market Periodical", "site": null, "reporter": "Antonio K Smith", "sentiment": "negative"}, {"title": "3 Biotech Stocks to Buy in the TradeSmith 'Green Zone'", "desc": null, "date": "21/12/2023", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8xMi8zLWJpb3RlY2gtc3RvY2tzLXRvLWJ1eS1pbi10aGUtdHJhZGVzbWl0aC1ncmVlbi16b25lL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iMkNnNXJSbE5DUVhWUE9ETTJkM05TVFJDb0FSaXNBaWdCTWdzQkFJVEZvT1lzQlV2c1hB=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Appoints Nancy Thornberry to its Board of Directors", "desc": null, "date": "05/12/2023", "link": "news.google.com/articles/CBMic2h0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMjMxMjA0NzM5ODYyL2VuL1ZlcnRleC1BcHBvaW50cy1OYW5jeS1UaG9ybmJlcnJ5LXRvLWl0cy1Cb2FyZC1vZi1EaXJlY3RvcnPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Appoints E. Morrey Atkinson, Ph.D., to EVP and Chief Technical Operations Officer, Head of Biopharmaceutical ...", "desc": null, "date": "29/08/2023", "link": "news.google.com/articles/CBMizwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMDgyOTEyMjcxNC9lbi9WZXJ0ZXgtQXBwb2ludHMtRS4tTW9ycmV5LUF0a2luc29uLVBoLkQuLXRvLUVWUC1hbmQtQ2hpZWYtVGVjaG5pY2FsLU9wZXJhdGlvbnMtT2ZmaWNlci1IZWFkLW9mLUJpb3BoYXJtYWNldXRpY2FsLVNjaWVuY2VzLWFuZC1NYW51ZmFjdHVyaW5nLU9wZXJhdGlvbnPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Q4 2022 Earnings Call Transcript", "desc": null, "date": "08/02/2023", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmZvb2wuY29tL2Vhcm5pbmdzL2NhbGwtdHJhbnNjcmlwdHMvMjAyMy8wMi8wOC92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtcTQtMjAyMi1lYXJuaW5ncy1jYWxsL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXJkblJrUTJWR2FqVlRYMHQyVFJEb0FSalpBU2dCTWdB=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals: Growth Is Still a Better Choice", "desc": null, "date": "14/12/2023", "link": "news.google.com/articles/CBMiWGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLWdyb3d0aC1zdGlsbC1iZXR0ZXItMTUzODExNzM1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTZVRWt5Wm5ORWVuTkROa3hWVFJEaEFSamhBU2dCTWdhWms1QnFOUVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Nathan Aisenstadt", "sentiment": "negative"}, {"title": "CRISPR (CRSP), Vertex Fall Despite FDA Nod to SCD Drug Casgevy", "desc": null, "date": "11/12/2023", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9jcmlzcHItY3JzcC12ZXJ0ZXgtZmFsbC1kZXNwaXRlLTE0NTEwMDAyNS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXBPRkZuUkZkNlYzZFlZMGhoVFJDeUFSaWJBaWdCTWdNTlVnWQ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies", "desc": null, "date": "26/06/2023", "link": "news.google.com/articles/CBMiWGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtbG9uemEtYnVpbGQtZGVkaWNhdGVkLW1hbnVmYWN0dXJpbmctMTEzMDAwMzQ4Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURSR1pKVnpVMGNHOTBNemx0VFJDakFSaTJBaWdCTWdZQllJYm0wUVE=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex (VRTX) Inks Licensing Deal With CRISPR for Diabetes Drug", "desc": null, "date": "28/03/2023", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vdWsubW92aWVzLnlhaG9vLmNvbS9maW5hbmNlL25ld3MvdmVydGV4LXZydHgtaW5rcy1saWNlbnNpbmctZGVhbC0xNDQxMDIyODMuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUZVMW95WkZsMlQwNUVTRnB5VFJDMEFSaVlBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Movies UK", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex (VRTX) Inks Licensing Deal With CRISPR for Diabetes Drug", "desc": null, "date": "28/03/2023", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vY2Euc3R5bGUueWFob28uY29tL2ZpbmFuY2UvbmV3cy92ZXJ0ZXgtdnJ0eC1pbmtzLWxpY2Vuc2luZy1kZWFsLTE0NDEwMjI4My5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUZVMW95WkZsMlQwNUVTRnB5VFJDMEFSaVlBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Canada Shine On", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "3 High-Growth Biotech Stocks Poised for Success in 2023", "desc": null, "date": "18/04/2023", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMy8wNC8zLWhpZ2gtZ3Jvd3RoLWJpb3RlY2gtc3RvY2tzLXBvaXNlZC1mb3Itc3VjY2Vzcy1pbi0yMDIzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNWhjM0Y0TUZOc01qUTBSVkUzVFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Chris Markoch", "sentiment": "positive"}, {"title": "Vertex Appoints Michel Lagarde to its Board of Directors", "desc": null, "date": "05/10/2023", "link": "news.google.com/articles/CBMicWh0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMjMxMDA1Nzg0OTYzL2VuL1ZlcnRleC1BcHBvaW50cy1NaWNoZWwtTGFnYXJkZS10by1pdHMtQm9hcmQtb2YtRGlyZWN0b3Jz0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex (VRTX): Streamlining DeFi Trading on Arbitrum", "desc": null, "date": "04/12/2023", "link": "news.google.com/articles/CBMiMWh0dHBzOi8vbGVhcm4uYnliaXQuY29tL2RlZmkvd2hhdC1pcy12ZXJ0ZXgtdnJ0eC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhUVEptUTNabFRHNXRaMnBLVFJDb0FSaXNBaWdCTWdZaFJZak5LUWM=-w200-h112-p-df", "media": "Bybit Learn", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Announces U.S. FDA Approval for TRIKAFTA\u00ae (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With ...", "desc": null, "date": "26/04/2023", "link": "news.google.com/articles/CBMi5AFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMDQyNjAwNTgxNS9lbi9WZXJ0ZXgtQW5ub3VuY2VzLVUuUy4tRkRBLUFwcHJvdmFsLWZvci1UUklLQUZUQSVDMiVBRS1lbGV4YWNhZnRvcnRlemFjYWZ0b3JpdmFjYWZ0b3ItYW5kLWl2YWNhZnRvci1pbi1DaGlsZHJlbi1XaXRoLUN5c3RpYy1GaWJyb3Npcy1BZ2VzLTItVGhyb3VnaC01LVdpdGgtQ2VydGFpbi1NdXRhdGlvbnPSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Clearwater Tribune Events - ZooTown Challenge Obstacle Course Race by VRTX Fitness @Washington-Grizzly Stadium", "desc": null, "date": "28/09/2023", "link": "news.google.com/articles/CBMioQFodHRwczovL3d3dy5jbGVhcndhdGVydHJpYnVuZS5jb20vbG9jYWwtZXZlbnRzLz9fZXZEaXNjb3ZlcnlQYXRoPS9ldmVudC8xMjg2NzZyLXpvb3Rvd24tY2hhbGxlbmdlLW9ic3RhY2xlLWNvdXJzZS1yYWNlLWJ5LXZydHgtZml0bmVzcy13YXNoaW5ndG9uLWdyaXp6bHktc3RhZGl1bdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNTBSVEkzU2pkbWJ5MWtOVUZZVFJERkFSal9BU2dCTWdrTmtvYm93T05qRGdJ=-w200-h112-p-df", "media": "Clearwater Tribune", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Announces FDA Clearance of Investigational New Drug Application for VX-264, a Novel Encapsulated Cell ...", "desc": null, "date": "09/03/2023", "link": "news.google.com/articles/CBMi0QFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMDMwODAwNTg5NC9lbi9WZXJ0ZXgtQW5ub3VuY2VzLUZEQS1DbGVhcmFuY2Utb2YtSW52ZXN0aWdhdGlvbmFsLU5ldy1EcnVnLUFwcGxpY2F0aW9uLWZvci1WWC0yNjQtYS1Ob3ZlbC1FbmNhcHN1bGF0ZWQtQ2VsbC1UaGVyYXB5LWZvci10aGUtVHJlYXRtZW50LW9mLVR5cGUtMS1EaWFiZXRlc9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY\u2122 (exagamglogene autotemcel) for the ...", "desc": null, "date": "08/12/2023", "link": "news.google.com/articles/CBMixgFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMTIwODk1MTczMy9lbi9WZXJ0ZXgtYW5kLUNSSVNQUi1UaGVyYXBldXRpY3MtQW5ub3VuY2UtVVMtRkRBLUFwcHJvdmFsLW9mLUNBU0dFVlklRTIlODQlQTItZXhhZ2FtZ2xvZ2VuZS1hdXRvdGVtY2VsLWZvci10aGUtVHJlYXRtZW50LW9mLVNpY2tsZS1DZWxsLURpc2Vhc2XSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharma is Moving in Rising Channel: Will Uptrend Continue?", "desc": null, "date": "18/11/2023", "link": "news.google.com/articles/CBMia2h0dHBzOi8vdGhlbWFya2V0cGVyaW9kaWNhbC5jb20vMjAyMy8xMS8xOC92ZXJ0ZXgtcGhhcm1hLWlzLW1vdmluZy1pbi1yaXNpbmctY2hhbm5lbC13aWxsLXVwdHJlbmQtY29udGludWUv0gFvaHR0cHM6Ly90aGVtYXJrZXRwZXJpb2RpY2FsLmNvbS8yMDIzLzExLzE4L3ZlcnRleC1waGFybWEtaXMtbW92aW5nLWluLXJpc2luZy1jaGFubmVsLXdpbGwtdXB0cmVuZC1jb250aW51ZS8_YW1w?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVlTR2xHWmpkc2JXdFpUSGMwVFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "The Market Periodical", "site": null, "reporter": "Nancy J. Allen", "sentiment": "negative"}, {"title": "Vertex Announces Positive Results From Phase 2 Study of VX-548 for the Treatment of Painful Diabetic Peripheral ...", "desc": null, "date": "13/12/2023", "link": "news.google.com/articles/CBMiswFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMTIxMzc3MzY0Ni9lbi9WZXJ0ZXgtQW5ub3VuY2VzLVBvc2l0aXZlLVJlc3VsdHMtRnJvbS1QaGFzZS0yLVN0dWR5LW9mLVZYLTU0OC1mb3ItdGhlLVRyZWF0bWVudC1vZi1QYWluZnVsLURpYWJldGljLVBlcmlwaGVyYWwtTmV1cm9wYXRoedIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "This healthcare stock could skyrocket anytime", "desc": null, "date": "26/11/2023", "link": "news.google.com/articles/CBMiQmh0dHBzOi8vZmluYm9sZC5jb20vdGhpcy1oZWFsdGhjYXJlLXN0b2NrLWNvdWxkLXNreXJvY2tldC1hbnl0aW1lL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXhSMkZFWkVGalRFSjRVWEZFVFJDM0FSaVRBaWdCTWdZSlVJaHd6UVE=-w200-h112-p-df", "media": "Finbold - Finance in Bold", "site": null, "reporter": "Ivan Zhelev", "sentiment": "negative"}, {"title": "Vertex Announces Publication in New England Journal of Medicine of Results from Phase 2 Study of Inaxaplin (VX-147)", "desc": null, "date": "16/03/2023", "link": "news.google.com/articles/CBMiqgFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMDMxNjAwNTE2MC9lbi9WZXJ0ZXgtQW5ub3VuY2VzLVB1YmxpY2F0aW9uLWluLU5ldy1FbmdsYW5kLUpvdXJuYWwtb2YtTWVkaWNpbmUtb2YtUmVzdWx0cy1mcm9tLVBoYXNlLTItU3R1ZHktb2YtSW5heGFwbGluLVZYLTE0N9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Jim Cramer: This Company Is 'Arranging Deck Chairs On The Titanic... Not A Believer'", "desc": null, "date": "06/10/2023", "link": "news.google.com/articles/CBMiiQFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy9qaW0tY3JhbWVyLXRoaXMtY29tcGFueS1pcy1hcnJhbmdpbmctZGVjay1jaGFpcnMtb24tdGhlLXRpdGFuaWMtbm90LWEtYmVsaWV2ZXItMTAzMjY4NDYwOdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTBURGhMWVdkQmJWaEphbXBsVFJEQ0FSaURBaWdCTWdhaFFKRE1IUWs=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Jim Cramer's Take on Vertex: Tackling Opioid Addiction with New Drug in Pipeline - Vertex Pharmaceuticals", "desc": null, "date": "09/10/2023", "link": "news.google.com/articles/CBMihgFodHRwczovL3d3dy5iZW56aW5nYS5jb20vZ2VuZXJhbC9iaW90ZWNoLzIzLzEwLzM1MTQ5MjY4L2ppbS1jcmFtZXJzLXRha2Utb24tdmVydGV4LXRhY2tsaW5nLW9waW9pZC1hZGRpY3Rpb24td2l0aC1uZXctZHJ1Zy1pbi1waXBlbGluZdIBLWh0dHBzOi8vd3d3LmJlbnppbmdhLmNvbS9hbXAvY29udGVudC8zNTE0OTI2OA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHpaVGR3UlVKQmVsSlNlR2N3VFJDM0FSaVRBaWdCTWdZVm80NUtPUVk=-w200-h112-p-df", "media": "Benzinga", "site": null, "reporter": "Vandana Singh", "sentiment": "negative"}, {"title": "Vertex Protocol: A Next-Generation DEX with a Unique Token Launch", "desc": null, "date": "15/11/2023", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vY29pbmdhcGUuY29tL2Jsb2cvdmVydGV4LXByb3RvY29sLWEtbmV4dC1nZW5lcmF0aW9uLWRleC13aXRoLWEtdW5pcXVlLXRva2VuLWxhdW5jaC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTJiV3MyZG1ZMFNXZDFNelZOVFJDb0FSaXNBaWdCTWdZTkZZN05QUVU=-w200-h112-p-df", "media": "CoinGape", "site": null, "reporter": "Stan Peterson", "sentiment": "negative"}, {"title": "Vertex (VRTX) to Report Q3 Earnings: What's in the Cards?", "desc": null, "date": "30/10/2023", "link": "news.google.com/articles/CBMigwFodHRwczovL3d3dy5tc24uY29tL2VuLXVzL21vbmV5L21hcmtldHMvdmVydGV4LXZydHgtdG8tcmVwb3J0LXEzLWVhcm5pbmdzLXdoYXQtcy1pbi10aGUtY2FyZHMvYXItQUExajVHYk8_b2NpZD1maW5hbmNlLXZlcnRocC1mZWVkc9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5hR3M1WjJKWlRGVjBOM0ZVVFJDMEFSaVlBaWdCTWdhTkFab01sUW8=-w200-h112-p-df", "media": "MSN", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Arbitrum\u2019s Vertex Protocol (VRTX) gains market share as user growth stalls", "desc": null, "date": "21/12/2023", "link": "news.google.com/articles/CBMia2h0dHBzOi8vaW52ZXp6LmNvbS9uZXdzLzIwMjMvMTIvMjEvYXJiaXRydW1zLXZlcnRleC1wcm90b2NvbC12cnR4LWdhaW5zLW1hcmtldC1zaGFyZS1hcy11c2VyLWdyb3d0aC1zdGFsbHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW5jMTlMU1dFd1ZUWlZZMDUyVFJDM0FSaVRBaWdCTWdZTlFJckxwQVU=-w200-h112-p-df", "media": "Invezz", "site": null, "reporter": "Crispus Nyaga", "sentiment": "negative"}, {"title": "A Pioneering Step in DeFi: Introducing Vertex Protocol's Token Launch", "desc": null, "date": "13/11/2023", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vYmVpbmNyeXB0by5jb20vcGlvbmVlcmluZy1zdGVwLWRlZmktdmVydGV4LXByb3RvY29sLXRva2VuLWxhdW5jaC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFWRzV3Ymt0blZrbzNkVU5EVFJDb0FSaXNBaWdCTWdZUkZZN05RUVU=-w200-h112-p-df", "media": "BeInCrypto", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "VRTX Stock Forecast: Will We See $400 this Year in (NASDAQ: VRTX)?", "desc": null, "date": "25/09/2023", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LnRoZWNvaW5yZXB1YmxpYy5jb20vMjAyMy8wOS8yNS92cnR4LXN0b2NrLWZvcmVjYXN0LXdpbGwtd2Utc2VlLTQwMC10aGlzLXllYXItaW4tbmFzZGFxLXZydHgv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVhZbTgzWDFkNWFtdE9MV1pQVFJDb0FSaXNBaWdCTWdZWm9vb3JRUVU=-w200-h112-p-df", "media": "The Coin Republic", "site": null, "reporter": "Andrew Smith", "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know", "desc": null, "date": "12/03/2024", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtc3RvY2stc2lua3MtMjE1MDE5Mzc1Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUpPVU5SZVRCaFpYcDBSVFpXVFJEQ0FSaURBaWdCTWdZQkFJNW5wUVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "VRTX Stock Dips; Can The Company Make Good On Plans To Replace Its Biggest Drug?", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L3ZydHgtc3RvY2stdmVydGV4LWVhcm5pbmdzLXE0LTIwMjMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXFla1ppVjBKM0xXWTVNakpwVFJDb0FSaXJBaWdCTWdZWmhwWUtOZ2M=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmZvb2wuY29tL2Vhcm5pbmdzL2NhbGwtdHJhbnNjcmlwdHMvMjAyNC8wMi8wNS92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtcTQtMjAyMy1lYXJuaW5ncy1jYWxsL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVVja1J1WXpoemJHZFVTR2t4VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts", "desc": null, "date": "23/01/2024", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtc3RvY2stZGlwcy0yMjUwMTkyMTkuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWpNWFUxTVVJelkxcExUM2s0VFJDM0FSaVRBaWdCTWdZQmNvb1NyUVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Here's Why IBD Stock Of The Day Vertex Is Now Actionable", "desc": null, "date": "23/02/2024", "link": "news.google.com/articles/CBMidmh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vcmVzZWFyY2gvaWJkLXN0b2NrLW9mLXRoZS1kYXkvdnJ0eC1zdG9jay1pYmQtc3RvY2stb2YtdGhlLWRheS1pcy1ub3ctYWN0aW9uYWJsZS1oZXJlLWlzLXdoeS_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNWxjMHN0UWpsbWRVNHlTV3hUVFJDakFSaTFBaWdCTWdPQkloZw=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "What Gives Vertex Pharmaceuticals Incorporated (VRTX) a Significant Competitive Advantage?", "desc": null, "date": "09/02/2024", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9naXZlcy12ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLWluY29ycG9yYXRlZC12cnR4LTExNDgyMTQ3MS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXRTR2RDWVZvNWEyWXRRalJzVFJDb0FSaXNBaWdCTWdZSk1veU1uUWM=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Soumya Eswaran", "sentiment": "negative"}, {"title": "Vertex (VRTX) Down 0.2% Since Last Earnings Report: Can It Rebound?", "desc": null, "date": "06/03/2024", "link": "news.google.com/articles/CBMiQmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtdnJ0eC1kb3duLTAtMi0xNjMwMTY1OTEuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNVdSMHBaUW01bWMzSk5hbGRSVFJETUFSajNBU2dCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight", "desc": null, "date": "15/02/2024", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9kZWNvZGluZy12ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLWluYy12cnR4LTA1MDYzMTI4OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUNibVJvTm1oNFFWbFJWV0l5VFJDeUFSaWJBaWdCTWdZRkE1UUtoZzA=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know", "desc": null, "date": "18/03/2024", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtYmVhdHMtc3RvY2stMjE1MDE4NzEzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVFNMEo1VGpWbWJGY3hZVUU1VFJDM0FSaVRBaWdCTWdrQmdJU0F4R05UMlFB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors", "desc": null, "date": "17/01/2024", "link": "news.google.com/articles/CBMiV2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtZGVjbGluZXMtbW9yZS0yMjUwMTcxOTEuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdSMHBaUW01bWMzSk5hbGRSVFJETUFSajNBU2dCTWdhbGxJak52UVE=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts", "desc": null, "date": "25/03/2024", "link": "news.google.com/articles/CBMiVmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtcmlzZXMtbWFya2V0LTIxNTAyMDQ2OC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUpPVU5SZVRCaFpYcDBSVFpXVFJEQ0FSaURBaWdCTWdZQkFJNW5wUVk=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "GSK vs. VRTX: Which Stock Is the Better Value Option?", "desc": null, "date": "05/03/2024", "link": "news.google.com/articles/CBMiRmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9nc2stdnMtdnJ0eC1zdG9jay1iZXR0ZXItMTY0MDA2OTE0Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTBjamRCY25ObGJpMUlOVWw1VFJDOEFSaU1BaWdCTWdhWmNvSkxMUU0=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Laps the Stock Market: Here's Why", "desc": null, "date": "29/01/2024", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtbGFwcy1zdG9jay0yMjUwMTgwNDUuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWFNVVIwVFV4a2FHVjRjRWhIVFJDM0FSaVRBaWdCTWdZbEJwRHNBUTA=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "PBYI or VRTX: Which Is the Better Value Stock Right Now?", "desc": null, "date": "24/01/2024", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9wYnlpLXZydHgtYmV0dGVyLXZhbHVlLXN0b2NrLTE2NDAxMDIwNS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVdSMHBaUW01bWMzSk5hbGRSVFJETUFSajNBU2dCTWdhbGxJak52UVE=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update", "desc": null, "date": "18/01/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaW90ZWNoLXN0b2NrLXJvdW5kdXAtdnJ0eC1jcnNwLTE1MjEwMDg0Ny5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNXlRbFJqYkc4NFpVeElWRk0yVFJDeUFSaWJBaWdCTWdtRmdZcjEwT1NDTkFF=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex's (VRTX) Non-Opioid Pain Drug Meets Primary Goal", "desc": null, "date": "31/01/2024", "link": "news.google.com/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXhzLXZydHgtbm9uLW9waW9pZC1wYWluLTE3MTgwMDc3Ni5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFjamMwT1ZwMU5tMUxRV05WVFJDeUFSaWJBaWdCTWdZWlU0b3NKUVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) Q4 Earnings and Revenues Top Estimates", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLXZydHgtcTQtZWFybmluZ3MtMjIyMDA0MzExLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNXhTVTFFTjJoUWQzQnlaMlpLVFJEaEFSamhBU2dCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2023 Earnings Call Transcript", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLWluY29ycG9yYXRlZC1uYXNkYXEtdnJ0eC0xMzM2MTY0NzIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW5iVTVUU0ZWMFptcFZkMWhpVFJDb0FSaXNBaWdCTWdZQlVJd3ZQUVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Insider Monkey", "sentiment": "negative"}, {"title": "Vertex (VRTX), CRSP's Casgevy Gets FDA Nod for Thalassemia", "desc": null, "date": "17/01/2024", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtdnJ0eC1jcnNwcy1jYXNnZXZ5LWdldHMtMTcwNDAwNzk5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNXBPRkZuUkZkNlYzZFlZMGhoVFJDeUFSaWJBaWdCTWdNTlVnWQ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Stay Ahead of the Game With Vertex (VRTX) Q4 Earnings: Wall Street's Insights on Key Metrics", "desc": null, "date": "31/01/2024", "link": "news.google.com/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9zdGF5LWFoZWFkLWdhbWUtdmVydGV4LXZydHgtMTQxNTE3NzU5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNUpTVE52VEVweVdFRkpWbFE0VFJDb0FSaXNBaWdCTWdB=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex (VRTX) Kidney Disease Drug to Enter Clinical Development", "desc": null, "date": "22/03/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtdnJ0eC1raWRuZXktZGlzZWFzZS1kcnVnLTE2MDkwMDc3MC5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZUMlpMVm1sTk4zaG5RMDlwVFJDeUFSaWJBaWdCTWdhUmNZaUlwZ2c=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex (VRTX), CRSP's Casgevy Gets EU Nod for Two Blood Disorders", "desc": null, "date": "14/02/2024", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtdnJ0eC1jcnNwcy1jYXNnZXZ5LWdldHMtMTIzMjAwNzkyLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXBSalZOTFhwb2FsbEJSMlI0VFJDeUFSaWJBaWdCTWdZQmtJeFB0UVU=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "VRTX Stock: Vertex's Alternative To Opioids Is 'Not A Game-Changer,' Says Analyst", "desc": null, "date": "30/01/2024", "link": "news.google.com/articles/CBMieWh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L3ZydHgtc3RvY2stc2tpZHMtaXRzLWFsdGVybmF0aXZlLXRvLW9waW9pZHMtaXMtbm90LWEtZ2FtZS1jaGFuZ2VyLXNheXMtYW5hbHlzdC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVJObWh0Vm5oemRIRkplVmhZVFJDZ0FSaTZBaWdCTWdaSk1aUzNHQW8=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "We Like The Quality Of Vertex Pharmaceuticals' (NASDAQ:VRTX) Earnings", "desc": null, "date": "22/02/2024", "link": "news.google.com/articles/CBMinAFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS12cnR4L3ZlcnRleC1waGFybWFjZXV0aWNhbHMvbmV3cy93ZS1saWtlLXRoZS1xdWFsaXR5LW9mLXZlcnRleC1waGFybWFjZXV0aWNhbHMtbmFzZGFxdnJ0eC1lYXLSAaABaHR0cHM6Ly9zaW1wbHl3YWxsLnN0L3N0b2Nrcy91cy9waGFybWFjZXV0aWNhbHMtYmlvdGVjaC9uYXNkYXEtdnJ0eC92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzL25ld3Mvd2UtbGlrZS10aGUtcXVhbGl0eS1vZi12ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLW5hc2RhcXZydHgtZWFyL2FtcA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlXVk5wU214VVkweGpjVWgwVFJDSEFSajJBaWdCTWdZdE5JeHdIUWs=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "VRTX: Top Biotech 3 Stocks With Accelerating Profits", "desc": null, "date": "13/03/2024", "link": "news.google.com/articles/CBMiZmh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL3ZydHgtZ21hYi1oYWxvLWFiYnYtcGZlLXRhay10b3AtYmlvdGVjaC0zLXN0b2Nrcy13aXRoLWFjY2VsZXJhdGluZy1wcm9maXRzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUhaM2xtVGtsb01qaDFaaTF4VFJDakFSaTJBaWdCTWdZMUlJVHp3QU0=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Mangeet Kaur", "sentiment": "positive"}, {"title": "Vertex (VRTX) to Report Q4 Earnings: What's in the Cards?", "desc": null, "date": "02/02/2024", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIyMjAzODAvdmVydGV4LXZydHgtdG8tcmVwb3J0LXE0LWVhcm5pbmdzLXdoYXRzLWluLXRoZS1jYXJkc9IBYWh0dHBzOi8vd3d3LnphY2tzLmNvbS9hbXAvc3RvY2svbmV3cy8yMjIwMzgwL3ZlcnRleC12cnR4LXRvLXJlcG9ydC1xNC1lYXJuaW5ncy13aGF0cy1pbi10aGUtY2FyZHM?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlkbTVSYTBsVGNuUmhhaTFoVFJDeUFSaWJBaWdCTWdhMVFZWXlwUWM=-w200-h112-p-df", "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "VRTX: Why Investors Are Flocking to These 2 Medical Stocks", "desc": null, "date": "09/02/2024", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL3ZydHgtbWNrLWctd2h5LWludmVzdG9ycy1hcmUtZmxvY2tpbmctdG8tdGhlc2UtMi1tZWRpY2FsLXN0b2Nrcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNW9hVVpCVUU0eGFUZzBZbkF0VFJDM0FSaVRBaWdCTWdrWlFwcjBHS3FTS2dJ=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Mangeet Kaur", "sentiment": "negative"}, {"title": "VRTX: Jumpstart Your Portfolio With These 3 Biotech Stocks", "desc": null, "date": "26/02/2024", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL3ZydHgtZXhlbC12bmRhLWJteS1yY3VzLWp1bXBzdGFydC15b3VyLXBvcnRmb2xpby13aXRoLXRoZXNlLTMtYmlvdGVjaC1zdG9ja3Mv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHpPVGczUVdGeVZFNUVOVGROVFJDM0FSaVRBaWdCTWdhQkFZWURqd3M=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Mangeet Kaur", "sentiment": "positive"}, {"title": "With EPS Growth And More, Vertex Pharmaceuticals (NASDAQ:VRTX) Makes An Interesting Case", "desc": null, "date": "15/01/2024", "link": "news.google.com/articles/CBMingFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS12cnR4L3ZlcnRleC1waGFybWFjZXV0aWNhbHMvbmV3cy93aXRoLWVwcy1ncm93dGgtYW5kLW1vcmUtdmVydGV4LXBoYXJtYWNldXRpY2Fscy1uYXNkYXF2cnR4LW0tMtIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWZjSFY1TUVsNU5WOUJORGxmVFJDREFSaUFBeWdCTWdheE5JeHdHUWs=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "Vertex Pharmaceuticals (NASDAQ:VRTX) shareholders have earned a 19% CAGR over the last five years", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMingFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS12cnR4L3ZlcnRleC1waGFybWFjZXV0aWNhbHMvbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLW5hc2RhcXZydHgtc2hhcmVob2xkZXJzLWhhdmUtZWFybmVkLWEtMdIBogFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS12cnR4L3ZlcnRleC1waGFybWFjZXV0aWNhbHMvbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLW5hc2RhcXZydHgtc2hhcmVob2xkZXJzLWhhdmUtZWFybmVkLWEtMS9hbXA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlXVk5wU214VVkweGpjVWgwVFJDSEFSajJBaWdCTWdZdE5JeHdIUWs=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Is Vertex Pharmaceuticals Stock a Buy Now?", "desc": null, "date": "06/01/2024", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDI0LzAxLzA2L2lzLXZlcnRleC1waGFybWFjZXV0aWNhbHMtc3RvY2stYS1idXktbm93L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUhXR3AyZFUxNWJHZGxSelpvVFJDM0FSaVRBaWdCTWdhWk40NXBuZ2s=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex's (VRTX) Q4 Earnings and Sales Surpass Estimates", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIyMjE4OTIvdmVydGV4cy12cnR4LXE0LWVhcm5pbmdzLWFuZC1zYWxlcy1zdXJwYXNzLWVzdGltYXRlc9IBYWh0dHBzOi8vd3d3LnphY2tzLmNvbS9hbXAvc3RvY2svbmV3cy8yMjIxODkyL3ZlcnRleHMtdnJ0eC1xNC1lYXJuaW5ncy1hbmQtc2FsZXMtc3VycGFzcy1lc3RpbWF0ZXM?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXZUMlpMVm1sTk4zaG5RMDlwVFJDeUFSaWJBaWdCTWdhUmNZaUlwZ2c=-w200-h112-p-df", "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex (VRTX) Continues to Diversify Beyond CF Franchise", "desc": null, "date": "25/03/2024", "link": "news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzIyNDUzNDgvdmVydGV4LXZydHgtY29udGludWVzLXRvLWRpdmVyc2lmeS1iZXlvbmQtY2YtZnJhbmNoaXNl0gFjaHR0cHM6Ly93d3cuemFja3MuY29tL2FtcC9zdG9jay9uZXdzLzIyNDUzNDgvdmVydGV4LXZydHgtY29udGludWVzLXRvLWRpdmVyc2lmeS1iZXlvbmQtY2YtZnJhbmNoaXNl?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUNaeTFzWVhwbmNHTldYM0pGVFJDeUFSaWJBaWdCTWdhcEJJclBEUXc=-w200-h112-p-df", "media": "Zacks Investment Research", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Reasons to Invest in Vertex Pharmaceuticals Incorporated (VRTX)", "desc": null, "date": "04/03/2024", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vd3d3Lmluc2lkZXJtb25rZXkuY29tL2Jsb2cvcmVhc29ucy10by1pbnZlc3QtaW4tdmVydGV4LXBoYXJtYWNldXRpY2Fscy1pbmNvcnBvcmF0ZWQtdnJ0eC0xMjY4NjYzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUlYMGt4UWpjeVpGRTBZbFkzVFJDb0FSaXNBaWdCTWdhQlFJd3ZQUVU=-w200-h112-p-df", "media": "Insider Monkey", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "VRTX: Dominate the Market With 3 Biotech Stocks", "desc": null, "date": "16/02/2024", "link": "news.google.com/articles/CBMiVGh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL3ZydHgtaW52YS1maHR4LWRvbWluYXRlLXRoZS1tYXJrZXQtd2l0aC0zLWJpb3RlY2gtc3RvY2tzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtZMmwyWVcxVU1VUnpVR2hzVFJDakFSaTJBaWdCTWdZTkJZS3VrUWs=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Dipanjan Banchur", "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals Stock Is Approaching a Huge Catalyst, But Is It a Buy?", "desc": null, "date": "08/02/2024", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDI0LzAyLzA4L3ZlcnRleC1waGFybWFjZXV0aWNhbHMtc3RvY2staXMtYXBwcm9hY2hpbmctYS1odWdlL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTVUbGhQU2sxbExVRkRXRUZoVFJDc0FSaWxBaWdCTWdZQllJekhOUVU=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": "Alex Carchidi", "sentiment": "negative"}, {"title": "CRSP Stock Dips Despite Snagging A Second Gene-Editing OK; VRTX Stock Continues On Its Warpath", "desc": null, "date": "16/01/2024", "link": "news.google.com/articles/CBMiiAFodHRwczovL3d3dy5pbnZlc3RvcnMuY29tL25ld3MvdGVjaG5vbG9neS9jcnNwLXN0b2NrLWRpcHMtZGVzcGl0ZS1zbmFnZ2luZy1hLXNlY29uZC1nZW5lLWVkaXRpbmctb2stdnJ0eC1zdG9jay1jb250aW51ZXMtb24taXRzLXdhcnBhdGgv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWZSWHBrWVVWMGFTMHhkVkZJVFJDb0FSaXNBaWdCTWdZNWdJeDVPQVk=-w200-h112-p-df", "media": "Investor's Business Daily", "site": null, "reporter": "Allison Gatlin", "sentiment": "negative"}, {"title": "Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits", "desc": null, "date": "04/03/2024", "link": "news.google.com/articles/CBMiXWh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMy9iaW90ZWNocy1vbi10aGUtcmlzZS0zLXN0b2Nrcy10by1idXktZm9yLWEtc2hvdC1vZi1wcm9maXRzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXRWelpSTkZsSWIyMXdXVlE0VFJDb0FSaXNBaWdCTWdhWk5JeUpIUWs=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Will Ashworth", "sentiment": "negative"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Price Target To US$452", "desc": null, "date": "07/02/2024", "link": "news.google.com/articles/CBMimwFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS12cnR4L3ZlcnRleC1waGFybWFjZXV0aWNhbHMvbmV3cy9lYXJuaW5ncy11cGRhdGUtaGVyZXMtd2h5LWFuYWx5c3RzLWp1c3QtbGlmdGVkLXRoZWlyLXZlcnRleNIBnwFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL25hc2RhcS12cnR4L3ZlcnRleC1waGFybWFjZXV0aWNhbHMvbmV3cy9lYXJuaW5ncy11cGRhdGUtaGVyZXMtd2h5LWFuYWx5c3RzLWp1c3QtbGlmdGVkLXRoZWlyLXZlcnRleC9hbXA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNVlXVk5wU214VVkweGpjVWgwVFJDSEFSajJBaWdCTWdZdE5JeHdIUWs=-w200-h112-p-df", "media": "Simply Wall St", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex's Addiction-Free Painkiller Meets Goal in Pivotal Trial", "desc": null, "date": "30/01/2024", "link": "news.google.com/articles/CBMidmh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDI0LTAxLTMwL3ZlcnRleC1zLXZydHgtYWRkaWN0aW9uLWZyZWUtcGFpbmtpbGxlci1tZWV0cy1nb2FsLWluLXBpdm90YWwtdHJpYWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUtTWE5GVDFWc2FuZEVkVzgyVFJDMkFSaVZBaWdCTWdZVmM0eXRMUWM=-w200-h112-p-df", "media": "Bloomberg", "site": null, "reporter": "Gerry Smith", "sentiment": "negative"}, {"title": "Where Will Vertex Pharmaceuticals Be in 10 Years?", "desc": null, "date": "25/01/2024", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDI0LzAxLzI1L3doZXJlLXdpbGwtdmVydGV4LXBoYXJtYWNldXRpY2Fscy1iZS1pbi0xMC15ZWFycy_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDNaRTFaWkhneFduWlpNVlZqVFJDM0FSaVRBaWdCTWdZMUU0NVJGUW8=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "1 Top Growth Stock to Buy and Hold Forever", "desc": null, "date": "31/03/2024", "link": "news.google.com/articles/CBMiVWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDI0LzAzLzMxLzEtdG9wLWdyb3d0aC1zdG9jay10by1idXktYW5kLWhvbGQtZm9yZXZlci_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXRORWhoYURKbGFGTkZlSFkyVFJDM0FSaVRBaWdCTWdhSlZaak5wUWc=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now", "desc": null, "date": "17/03/2024", "link": "news.google.com/articles/CBMiWmh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDI0LzAzLzE3LzItbm8tYnJhaW5lci1oZWFsdGhjYXJlLXN0b2Nrcy10by1idXktd2l0aC0xMDAwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUZVa1oyZEhObFIxbFVZbHBHVFJDM0FSaVRBaWdCTWdrSmNvN3lxS2V4ekFF=-w200-h112-p-df", "media": "The Motley Fool", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "3 Biotech Stocks to Buy for the Next Bull Run: March 2024", "desc": null, "date": "26/03/2024", "link": "news.google.com/articles/CBMiW2h0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMy8zLWJpb3RlY2gtc3RvY2tzLXRvLWJ1eS1mb3ItdGhlLW5leHQtYnVsbC1ydW4tbWFyY2gtMjAyNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUVkVEp4T0RadlZXRkNjRzVGVFJDb0FSaXNBaWdCTWdZSkFwRE5uUWM=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals EVP, Global Research and CSO David Altshuler Sells 4,002 Shares", "desc": null, "date": "21/02/2024", "link": "news.google.com/articles/CBMiWGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGhhcm1hY2V1dGljYWxzLWV2cC1nbG9iYWwtcmVzZWFyY2gtMjIwMDM4NzM5Lmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNW5iVUUwWjBoUWFqSmZVVlE1VFJDVUFSalVBaWdCTWdNQkFndw=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "3 Secret Stocks to Double Your Money by 2028", "desc": null, "date": "22/02/2024", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMi8zLXNlY3JldC1zdG9ja3MtdG8tZG91YmxlLXlvdXItbW9uZXktYnktMjAyOC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTJSMEpWVkRkR2FWUjZWVmhsVFJDb0FSaXNBaWdCTWdZWmxZaXB1UVU=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Terel Miles", "sentiment": "negative"}, {"title": "Vertex: Q4 Earnings Snapshot", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMiNWh0dHBzOi8vcXouY29tL3ZlcnRleC1xNC1lYXJuaW5ncy1zbmFwc2hvdC0xODUxMjI3Mzgy0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iI0NnNDNOMVJFZDFaV1VUUkplVmx4VFJDcEFSaXJBaWdCTWdB=-w200-h112-p-df", "media": "Quartz", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "3 Healthcare Stocks to Make You the Millionaire Next Door: 2024 Edition", "desc": null, "date": "03/01/2024", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMS8zLWhlYWx0aGNhcmUtc3RvY2tzLXRvLW1ha2UteW91LXRoZS1taWxsaW9uYWlyZS1uZXh0LWRvb3ItMjAyNC1lZGl0aW9uL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNW9hV2xyWlhBMmNrWndSM0poVFJDb0FSaXNBaWdCTWdhQllaTFVyQVk=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Jeremy Flint", "sentiment": "negative"}, {"title": "3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List", "desc": null, "date": "09/02/2024", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMi8zLXN0cm9uZy1idXktaGVhbHRoY2FyZS1zdG9ja3MtdG8tYWRkLXRvLXlvdXItZmVicnVhcnktbXVzdC13YXRjaC1saXN0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNU5SelIyTWxCelJraHRjamN5VFJDb0FSaXNBaWdCTWdhdElZUVBwUUk=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Jeremy Flint", "sentiment": "negative"}, {"title": "Top Stock Reports for JPMorgan Chase, Salesforce & Vertex Pharmaceuticals", "desc": null, "date": "26/02/2024", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy90b3Atc3RvY2stcmVwb3J0cy1qcG1vcmdhbi1jaGFzZS0xOTA2MDA0MDAuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNVNTWFp5VkZSQ01rWlpTMHhOVFJDeUFSaWJBaWdCTWdrSlVKWUhxaWcwaVFJ=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": "Mark Vickery", "sentiment": "positive"}, {"title": "Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal ...", "desc": null, "date": "21/03/2024", "link": "news.google.com/articles/CBMiXGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtYW5ub3VuY2VzLWZkYS1jbGVhcmFuY2UtaW52ZXN0aWdhdGlvbmFsLTEyMDAwMDA0OS5odG1s0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURSR1pKVnpVMGNHOTBNemx0VFJDakFSaTJBaWdCTWdZQllJYm0wUVE=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Announces US FDA Approval of CASGEVY\u2122 (exagamglogene autotemcel) for the Treatment of Transfusion ...", "desc": null, "date": "16/01/2024", "link": "news.google.com/articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtYW5ub3VuY2VzLXVzLWZkYS1hcHByb3ZhbC0xOTI0MDAyODIuaHRtbNIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURSR1pKVnpVMGNHOTBNemx0VFJDakFSaTJBaWdCTWdZQllJYm0wUVE=-w200-h112-p-df", "media": "Yahoo Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings", "desc": null, "date": "07/01/2024", "link": "news.google.com/articles/CBMijwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDI0MDEwNzE4ODE3NC9lbi9WZXJ0ZXgtUHJvdmlkZXMtUGlwZWxpbmUtYW5kLUJ1c2luZXNzLVVwZGF0ZXMtaW4tQWR2YW5jZS1vZi1VcGNvbWluZy1JbnZlc3Rvci1NZWV0aW5nc9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFTSFJHVVRWeExUVTJlbVJMVFJDZkFSaS1BaWdCTWdhSllZYnEwQVE=-w200-h112-p-df", "media": "Business Wire", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires", "desc": null, "date": "19/03/2024", "link": "news.google.com/articles/CBMiZmh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMy9mcm9tLXNpeC1maWd1cmVzLXRvLXNldmVuLTMtYmlvdGVjaC1zdG9ja3Mtc2V0LXRvLW1ha2UtbWlsbGlvbmFpcmVzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUVkVEp4T0RadlZXRkNjRzVGVFJDb0FSaXNBaWdCTWdZSkFwRE5uUWM=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Muslim Farooque", "sentiment": "negative"}, {"title": "Vertex Pharmaceuticals (VRTX) should remain supported", "desc": null, "date": "27/02/2024", "link": "news.google.com/articles/CBMiXmh0dHBzOi8vd3d3LmZ4c3RyZWV0LmNvbS9uZXdzL3ZlcnRleC1waGFybWFjZXV0aWNhbHMtdnJ0eC1zaG91bGQtcmVtYWluLXN1cHBvcnRlZC0yMDI0MDIyNzExNDLSAWJodHRwczovL3d3dy5meHN0cmVldC5jb20vYW1wL25ld3MvdmVydGV4LXBoYXJtYWNldXRpY2Fscy12cnR4LXNob3VsZC1yZW1haW4tc3VwcG9ydGVkLTIwMjQwMjI3MTE0Mg?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNDFMVm8zYm5wRlYwWkVUelJZVFJDM0FSaVRBaWdCTWdhaFpJWUxKZ2c=-w200-h112-p-df", "media": "FXStreet", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "3 Biotech Stocks Set for Breakthroughs in 2024", "desc": null, "date": "02/01/2024", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMS8zLWJpb3RlY2gtc3RvY2tzLXNldC1mb3ItYnJlYWt0aHJvdWdocy1pbi0yMDI0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhNREZ1WVZSYWJHRXplbk5RVFJDb0FSaXNBaWdCTWdZSmNwQXdLUWM=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Terel Miles", "sentiment": "negative"}, {"title": "Vertex's Next-Generation Cystic Fibrosis Program Shows Efficacy With Reduced Burden, Provides Growth Opportunity ...", "desc": null, "date": "06/02/2024", "link": "news.google.com/articles/CBMiuAFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy92ZXJ0ZXgtcy1uZXh0LWdlbmVyYXRpb24tY3lzdGljLWZpYnJvc2lzLXByb2dyYW0tc2hvd3MtZWZmaWNhY3ktd2l0aC1yZWR1Y2VkLWJ1cmRlbi1wcm92aWRlcy1ncm93dGgtb3Bwb3J0dW5pdHktZ29sZG1hbi1zYWNocy0xMDMzMDM2NjQw0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNTNTR3gzY1dZemNUaFBUemd5VFJEQ0FSaURBaWdCTWdhUm9vNUtPUVk=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": null, "sentiment": "positive"}, {"title": "3 Must-Buy Healthcare Stocks for a Healthy 2024", "desc": null, "date": "22/01/2024", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMS8zLW11c3QtYnV5LWhlYWx0aGNhcmUtc3RvY2tzLWZvci1hLWhlYWx0aHktMjAyNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNHhOSHBpVG1kT1JTMU5UREpRVFJDb0FSaXNBaWdCTWdhdElZUVBKUU0=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Terel Miles", "sentiment": "negative"}, {"title": "Vertex says it's on track for five product launches by 2028 - Boston Business Journal", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMiTGh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9ib3N0b24vbmV3cy8yMDI0LzAyLzA1L3ZlcnRleC0yMDIzLWVhcm5pbmdzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNUhZV2sxVEVNMmRuQjRiMjlOVFJDb0FSaXNBaWdCTWdhWllZN1JPQVk=-w200-h112-p-df", "media": "The Business Journals", "site": null, "reporter": "Hannah Green", "sentiment": "positive"}, {"title": "5 Biotech Stocks with Huge Potential", "desc": null, "date": "08/03/2024", "link": "news.google.com/articles/CBMiUWh0dHBzOi8vd3d3Lmluc2lkZXJtb25rZXkuY29tL2Jsb2cvNS1iaW90ZWNoLXN0b2Nrcy13aXRoLWh1Z2UtcG90ZW50aWFsLTEyNjY4OTQvNdIBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXBSVWhyVFZwQmFVeEJVRkpWVFJDb0FSaXNBaWdCTWdZaE5JS09tUWs=-w200-h112-p-df", "media": "Insider Monkey", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "Buy Alert: 3 Stocks Sitting in the Sweet Spot", "desc": null, "date": "31/01/2024", "link": "news.google.com/articles/CBMiT2h0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMS9idXktYWxlcnQtMy1zdG9ja3Mtc2l0dGluZy1pbi10aGUtc3dlZXQtc3BvdC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUpORkZMV0VrMVNYSTBRVXBGVFJDb0FSaXNBaWdCTWdrUmhJU3V4U1NxamdF=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Chandler Capital", "sentiment": "negative"}, {"title": "Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements", "desc": null, "date": "01/02/2024", "link": "news.google.com/articles/CBMiaGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyNC8wMi90b3Atc3RvY2stcGlja3MtMjAyNC0zLWhlYWx0aGNhcmUtc3RvY2tzLWxlYWRpbmctbWVkaWNhbC1hZHZhbmNlbWVudHMv0gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iL0NnNUdSV1YyTkVGak5WVnlkblpLVFJDb0FSaXNBaWdCTWdrTkFJclZtT2VaUUFN=-w200-h112-p-df", "media": "InvestorPlace", "site": null, "reporter": "Faizan Farooque", "sentiment": "positive"}, {"title": "Vertex to Participate in Upcoming Investor Conferences", "desc": null, "date": "20/02/2024", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vY2EuZmluYW5jZS55YWhvby5jb20vbmV3cy92ZXJ0ZXgtcGFydGljaXBhdGUtdXBjb21pbmctaW52ZXN0b3ItY29uZmVyZW5jZXMtMjEwNTAwNjEzLmh0bWzSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNURSR1pKVnpVMGNHOTBNemx0VFJDakFSaTJBaWdCTWdZQllJYm0wUVE=-w200-h112-p-df", "media": "Yahoo Canada Finance", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "3 Biotech Stocks Set for Breakthroughs in 2024 | Markets Insider", "desc": null, "date": "02/01/2024", "link": "news.google.com/articles/CBMiaWh0dHBzOi8vbWFya2V0cy5idXNpbmVzc2luc2lkZXIuY29tL25ld3Mvc3RvY2tzLzMtYmlvdGVjaC1zdG9ja3Mtc2V0LWZvci1icmVha3Rocm91Z2hzLWluLTIwMjQtMTAzMjkzNzc4N9IBAA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXRVMjlyVFZKM2JFcDJjVWQ0VFJDb0FSaXJBaWdCTWdZWnBwSUp1Z1k=-w200-h112-p-df", "media": "Markets Insider", "site": null, "reporter": "Terel Miles", "sentiment": "negative"}, {"title": "Noteworthy ETF Outflows: TQQQ, CMCSA, VRTX, SBUX", "desc": null, "date": "28/02/2024", "link": "news.google.com/articles/CBMiTWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvbm90ZXdvcnRoeS1ldGYtb3V0Zmxvd3M6LXRxcXEtY21jc2EtdnJ0eC1zYnV40gEA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iJ0NnNVhibVU0UjI1dFlYZGZTbVJDVFJDM0FSaVRBaWdCTWdPSkVnQQ=-w200-h112-p-df", "media": "Nasdaq", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "IWY, ISRG, SBUX, VRTX: Large Outflows Detected at ETF", "desc": null, "date": "18/03/2024", "link": "news.google.com/articles/CBMiUmh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvaXd5LWlzcmctc2J1eC12cnR4Oi1sYXJnZS1vdXRmbG93cy1kZXRlY3RlZC1hdC1ldGbSAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNWlaa2MxT1U1cFJFVlVXV056VFJDM0FSaVRBaWdCTWdZQkE0ck1NUWc=-w200-h112-p-df", "media": "Nasdaq", "site": null, "reporter": null, "sentiment": "negative"}, {"title": "AMGN: Analyzing 3 Biotech Stocks for 2024 Gain Potential", "desc": null, "date": "05/02/2024", "link": "news.google.com/articles/CBMiYWh0dHBzOi8vc3RvY2tuZXdzLmNvbS9uZXdzL2FtZ24tdnJ0eC1hbGtzLW52by1hbmFseXppbmctMy1iaW90ZWNoLXN0b2Nrcy1mb3ItMjAyNC1nYWluLXBvdGVudGlhbC_SAQA?hl=en-US&gl=US&ceid=US%3Aen", "img": "news.google.com/api/attachments/CC8iK0NnNXVkRlV0Y0c1TFdtbzVXbU5RVFJDM0FSaVRBaWdCTWdhQllwUnVvUWc=-w200-h112-p-df", "media": "StockNews.com", "site": null, "reporter": "Kritika Sarmah", "sentiment": "negative"}]